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There is a rising prevalence of sleep disordered breathing (SDB) globally and 
there is mounting evidence to show that SDB is closely associated with 
cardiovascular diseases. However, this disease is currently under-recognized 
and improved detection is required for timely intervention. The current gold 
standard for diagnosis, in-laboratory polysomnography has limited 
availability. In order to cope with the rising demand for sleep studies, several 
SDB screening questionnaires and portable sleep monitoring devices have 
been developed to help rule out those at low risk and to replace the need for 
traditional in-laboratory polysomnography in certain individuals with high 
pre-test probabilities of SDB. 
 
In this thesis, different studies were performed on various cohorts. Firstly, the 
prevalence and public awareness of SDB was studied in a healthy subgroup of 
participants from the Singapore Health Study 2012. At the same time, the 
usefulness of three screening questionnaires (STOP-BANG, Berlin 
Questionnaire and NoSAS score) in predicting SDB within the local 
population was investigated on the same cohort. Next, we explored the ability 
of different questionnaires (STOP-BANG, Berlin Questionnaire and Epworth 
Sleepiness Scale) to predict exercise fitness in a cohort of patients enrolled for 
late-phase cardiac rehabilitation. The final study was performed in a cohort of 
subjects signed-up for a cardiovascular health-screening package. The 
associations between SDB and several coronary risk markers (such as the 
high-sensitivity C-reactive protein) measured as part of the package were 
examined. Lastly, we determined the feasibility of incorporating SDB 
 xi 
screening into cardiovascular health-screening programs by observing the 
flow of the study. 
 
The whole population estimate of moderate-to-severe SDB in Singapore was 
found to be relatively high at 30.5%. Ethnic differences in prevalence were 
observed, with Malays having the highest rates (33.8%), followed by Chinese 
(32.1%) and Indians (16.5%). Public awareness of SDB was poor as only a 
third of those interviewed could correctly define SDB and this was found to be 
due to low education, ethnicity (Malays and Indians), and presence of 
moderate-to-severe SDB. All three SDB screening questionnaires (STOP-
BANG, Berlin Questionnaire and NoSAS score) have similar predictive 
powers in ruling out severe SDB and might have potential use as preliminary 
screening tools in view of their high negative predictive powers (>94%) in the 
local general population setting.  In terms of the ability to predict exercise 
fitness, it was observed that Berlin Questionnaire was superior to both STOP-
BANG and Epworth Sleepiness Scale in defining cardiac rehabilitation 
patients at risk for SDB as these patients performed worse (walked 20 meters 
lesser) on the six minute walk test than those who were defined as low risk of 
SDB. Finally, SDB was found to be independently associated with higher 
serum high-sensitivity C-reactive protein levels (relative mean difference 
1.29), higher serum triglyceride levels (relative mean difference 1.15), and 
lower exercise capacity (mean difference –26.4 seconds) among participants 
of cardiovascular health screening. Furthermore, incorporation of SDB 
screening into health screening programs seems feasible as the screening was 
 xii 
quite well accepted (65.7%) and could detect SDB in many participants (38%) 
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CHAPTER 1: INTRODUCTION 
1.1 SLEEP DISORDERED BREATHING 
Sleep disordered breathing (SDB) comprises different types of nocturnal 
respiratory disorders including obstructive sleep apnea, central sleep apnea 
and mixed apnea. Patients with these disorders often experience intermittent 
cessation of breathing during sleep, causing repetitive oxygen desaturation, 
arousal and sleep fragmentation. There are a number of common risk factors 
for SDB including age, obesity, male gender, and craniofacial 
constrictions.(Usmani, Chai-Coetzer, Antic, & McEvoy, 2013) Obstructive 
sleep apnea, the most common form of SDB, is characterized by recurring 
upper airway obstruction leading to complete or partial blockage of airflow. 
Figure 1 illustrates this process of obstruction. In contrast, central sleep apnea 
is caused by the lack of drive to breathe and could be discriminated from 
obstructive sleep apnea through the absence of ventilatory efforts. Mixed 
apnea, as the name suggests, is a combination of both obstructive and central 
sleep apnea in which patients suffer from both reduced airway patency and 
lack of ventilatory efforts. Table 1 summarizes these three types of sleep 











Figure 1. Hypopnea and apnea resulting from blockage of the upper airway.  























of air flow due to: 
x Loss of upper 
airway muscle 
tone 
x Excess upper 
airway tissues  
x Structure of the 
cranium, face and 
upper airway 
x Snoring 
x Reduced/no airflow 
x Blood oxygen 
desaturation 
x Frequent arousals 




Lack of respiratory 
signals from brain centers 
that control the activities 
of respiratory muscles 
(Pack, 2006) 
 
x Absence of respiratory 
efforts 
x No airflow 
x Blood oxygen 
desaturation 
x Frequent arousals 
x Excessive day time 
sleepiness 
Mixed apnea Both blockage of airflow 
and the lack of respiratory 
drive 
x Absence of respiratory 
efforts initially, followed 
by some respiratory 
efforts in the later part of 
the event 
x Reduced/no airflow 
x Blood oxygen 
desaturation 
x Frequent arousals 
x Excessive day time 
sleepiness 












1.2 REDUCING PREMATURE CARDIOVASCULAR DEATHS- 
IMPLICATIONS ON SDB PREVENTION 
In 2011, the United Nations set a key target to reduce the risk of mortality 
from premature noncommunicable diseases by 25% by 2025, particularly 
cardiovascular disease which is the major contributor, accounting for about 
half of the annual noncommunicable disease mortality.(Sacco et al., 2016) 
Selected traditional cardiovascular disease risk factors such as hypertension, 
smoking, diabetes mellitus and obesity have been targeted for reduction to 
achieve the United Nation’s goal. Despite all four risk factors being reduced to 
their target levels in the most optimistic scenario, it is projected that the 2025 
goal is unachievable by many countries.(Roth et al., 2015) This is particularly 
worrying as the predicted number of premature deaths from cardiovascular 
diseases will still be high at 5.7 million in 2025. In order to achieve the United 
Nation’s goal, other non-traditional cardiovascular risk factor targets such as 
SDB should be recognized and aggressively addressed too. In addition, the 
American Heart Association/American College of Cardiology Foundation 
Scientific Statement on Sleep Apnea and Cardiovascular Disease has called 
for an expanded knowledge base to understand the role of SDB in initiating 
the development of cardiac and vascular diseases. Indeed, a better 
understanding of the relationship between SDB and cardiovascular diseases is 








1.3 ASSOCIATION BETWEEN SDB AND CARDIOVASCULAR 
DISEASES 
Currently, SDB is an emerging threat to cardiac health in the community as 
associations have been found between SDB and several disorders such as 
coronary artery disease, hypertension, heart failure, arrhythmias and 
stroke.(Budhiraja, Budhiraja, & Quan, 2010) Cardiac events were observed to 
occur more frequently during sleep than in the day time among SDB patients 
with preexisting cardiac conditions as compared to patients without SDB.(Sert 
Kuniyoshi et al., 2008) 
 
1.3.1 Coronary Artery Disease 
There is increasing evidence that SDB is associated with coronary 
atherosclerosis as incidence of coronary artery disease and related adverse 
events are higher in patients with SDB versus those without.(L. F. Drager, 
Bortolotto, Figueiredo, Krieger, & Lorenzi, 2007; Peker et al., 1999; Shahar et 
al., 2001; Adeline Tan et al., 2014) Coronary artery calcification, which is a 
marker of developing coronary artery disease was found to be more prevalent 
in individuals with SDB (67%) than those without (31%) and a dose-response 
relationship in the odds of coronary artery calcification and SDB severity was 
observed.(Sorajja et al., 2008) Early signs of atherosclerosis in the blood 
vessels, assessed by carotid intima-media thickness (707 versus 645) and 
arterial stiffness (as measured by pulse-wave velocity; 10.4 versus 9.3) were 
improved following continuous positive airway pressure (CPAP) treatment in 
severe SDB patients.(Luciano F. Drager, Bortolotto, Figueiredo, Krieger, & 
Lorenzi-Filho, 2007) Another small study that performed coronary computed 




tomographic angiography found that those with more severe SDB had a higher 
coronary plaque volume.(Brian D. Kent et al., 2013) Figure 2 depicts the 
presence of coronary plaque in a SDB patient. 
 
The Wisconsin Sleep Cohort Study is a prospective, community based study 
conducted on 1546 participants from south-central Wisconsin that assesses its 
participants at every four year intervals to gather information on sleep 
disorders and the associated risk factors and adverse outcomes.(K. M. Hla et 
al., 2015) A longitudinal analysis of this study demonstrated that incident 
coronary artery disease was 2.6 times more likely to occur in individuals with 
severe SDB than healthy individuals and the hazard ratios were observed to 
increase with SDB severity.(K. M. Hla et al., 2015) Similar to the Wisconsin 
Sleep Cohort, the Sleep Heart Health Study is another large scale multi-centre 
community based study investigating the cardiovascular outcomes of SDB. It 
involves 6441 individuals from several existing parent cohorts that study 
cardiovascular diseases.(Gottlieb et al., 2010) Prospective analysis of 
participants in the Sleep Heart Healthy Study found that coronary artery 
disease was 68% more likely to occur in middle-aged men with severe SDB 
relative to those without SDB.(Gottlieb et al., 2010) The disease free survival 
curves for both men and women in this study are shown in Figure 3. In 
addition, those with SDB who were treated sufficiently had lower incidence of 
cardiovascular disease than those who were inadequately treated (6.7% versus 
56.8%). This increased incident cardiovascular events among SDB patients 
was also observed in another study.(Jose M. Marin, Carrizo, Vicente, & 
Agusti) In this study, a cohort of 1651 men consisting of patients referred to 




sleep clinic and healthy men from a population-based study was investigated. 
The participants were followed up at least once a year for a mean of 10.1 
years.  Incidences of both fatal and non-fatal cardiovascular events were the 
highest among untreated severe SDB patients, followed by those who had less 
severe SDB and were untreated. The risk of cardiovascular events was low 
and similar among SDB patients who underwent treatment, snorers without 












Figure 2. Coronary artery of a healthy control versus SDB patient (Brian D. Kent et al., 2013) Coronary computed tomographic 
angiography images from study subjects. a) left anterior descending (LAD) healthy control; b) right coronary artery healthy 
control; c) LAD of obstructive sleep apnoea patient with distal calcified plaque (arrow); d) 1-mm cross-sectional slice through the 
distal LAD plaque, showing a patent lumen (straight arrow) and the plaque (curved arrow); e) calculation of the plaque volume; f) 
invasive coronary angiogram of the same patient confirming an obstructive distal LAD stenosis (arrow). 





Figure 3. The coronary heart disease (CHD)- and congestive heart failure (CHF)- free survival curves of different genders. 
(Gottlieb et al., 2010)  





As established in several different patient cohorts, the odds of hypertension 
increased with the severity of SDB.(José M. Marin et al., 2012; Nieto, Young, 
Lind, & et al., 2000; Paul E. Peppard, Young, Palta, & Skatrud, 2000) 
Participants in the Wisconsin Sleep Study Cohort demonstrated that among 
those with moderate-to-severe SDB, the odds of hypertension after four years 
was 2.89 compared to those without SDB and the odds increased with disease 
severity.(Paul E. Peppard et al., 2000) On the contrary, the Sleep Heart Health 
Study did not find any significant relationship between SDB and hypertension 
risk following adjustment for body mass index (BMI).(O'Connor et al., 2009) 
Nevertheless, a modest association between severe SDB and incident 
hypertension could not be ruled out (odds ratio 1.51). Among perimenopausal 
women, hypertension was more prevalent in those with moderate-to-severe 
SDB than those without SDB.(Pedrosa et al., 2014) Both the diurnal and 
nocturnal blood pressures were also higher in these SDB patients. An 
important risk factor for hypertension, nocturnal non-dipping of systolic blood 
pressure was also found to be more prevalent in moderate-to-severe SDB 
patients (adjusted odds ratio of 4.4) compared to those without SDB.(Khin 









1.3.3 Heart Failure 
A cross-sectional analysis of the Sleep Heart Health Study revealed that 
participants with SDB had an odds ratio of 2.38 in the incidence of self-
reported heart failure relative compared to those without SDB.(Shahar et al., 
2001) In a separate longitudinal analysis of the participants in the same study, 
incident heart failure was 58% more likely to occur in men with severe SDB 
versus those without SDB.(Gottlieb et al., 2010) Figure 2 illustrates the 
congestive heart failure free survival curves of these participants. On the 
contrary, another study found that only women with SDB had higher risk of 
incident heart failure and left ventricular hypertrophy 13 years later.(Roca et 
al., 2015) A study on SDB patients without known cardiac diseases who were 
admitted for CPAP therapy discovered that SDB treatment could potentially 
reverse left ventricular systolic dysfunction that could eventually lead to heart 
failure.(Laaban et al., 2002) An even smaller study conducted on severe SDB 
patients demonstrated that SDB was associated with left ventricular 
hypertrophy (88%), left atrial enlargement (64%), right atrial enlargement 
(48%), and right ventricular hypertrophy (16%).(Cloward, Walker, Farney, & 
Anderson, 2003) Following SDB treatment with CPAP for six months, there 









Atrial fibrillation have been shown to occur at increased odds of 4.02 times 
among individuals in the Sleep Heart Health Study with severe SDB relative 
to those without.(Mehra et al., 2006) Results from another large-scale multi-
site cohort study involving more than 6000 community individuals corroborate 
this finding and also showed that individuals with better sleep quality 
(indicated by longer periods of slow wave sleep) had lower odds (0.68) of 
atrial fibrillation.(Kwon et al., 2015) In one study conducted in Japan, 
paroxysmal atrial fibrillation which was found to be associated with SDB, 
improved significantly following CPAP treatment.(Abe et al., 2010) To 
further support the notion that SDB predisposes individuals to atrial 
fibrillation, a small-scale study showed that the severity of cardiac rhythm 
disturbances increased with SDB severity and short-term CPAP therapy 
resolved these disturbances.(Harbison, O'Reilly, & McNicholas, 2000)  
 
1.3.5 Stroke 
A cross-sectional analysis of the Wisconsin Sleep Study Cohort indicated that 
SDB was associated with prevalent stroke (odds ratio of 4.33 relative to those 
without SDB). At follow up four years later, those with SDB had 4.31 odds of 
incident stroke, although this was no longer significant after adjustment for 
potential confounders.(Arzt, Young, Finn, Skatrud, & Bradley, 2005) 
Nevertheless, another relatively large-scale study showed that SDB was an 
independent risk factor for stroke or death from any cause with an adjusted 
hazard ratio of 1.97 compared to those without SDB.(Yaggi et al., 2005) 
Among participants in the Sleep Heart Health Study, SDB in men was 




associated with ischemic stroke (adjusted hazard ratio of 2.86) and this 
increased risk of stroke rose with severity of SDB. Although not significant, 
the risk of stroke was observed to also increase among women with more 
severe forms of SDB.(Susan Redline et al., 2010)   
 
1.3.6 Other Cardiovascular Risk Markers 
One important negative consequence of SDB is frequent intermittent hypoxia 
that has been implicated in the progression of oxidative stress, systemic 
inflammation, autonomic and endothelial dysfunctions.(Baguet, Barone-
Rochette, Tamisier, Levy, & Pepin, 2012; Emin et al., 2016) These could be 
the intermediate steps which ultimately contribute to the observed associations 
of SDB with impaired cardiovascular and neurocognitive health, lipid and 
glucose metabolic dysfunctions, reduced exercise fitness and all-cause 
mortality in numerous studies.(L. F. Drager, Jun, & Polotsky, 2010; Jordan, 
McSharry, & Malhotra, 2014; Lavie et al., 1995; W. Lee, Nagubadi, Kryger, 
& Mokhlesi, 2008; Somers et al., 2008; Vanuxem et al., 1997) Figure 4 
illustrates a possible mechanism through which the above intermediary 
disorders contribute to adverse cardiovascular outcomes. 
 
To better understand the relationship between SDB and various cardiovascular 
risk markers, several studies have been conducted. Although inflammatory 
markers such as the high-sensitivity C-reactive protein (hs-CRP) have been 
extensively investigated, no definite conclusion about the relationship between 
SDB and hs-CRP has been reached to date. While early studies with small 
sample size revealed promising association between SDB and hs-




CRP,(Shamsuzzaman et al., 2002) subsequent large-scale population studies 
have reported conflicting results.(Arnardottir et al., 2012; Svensson, Venge, 
Janson, & Lindberg, 2012) Hemodynamic variables such as cardiac output and 
contractility index which are indicators of cardiac performance were also 
significantly decreased in cardiac rehabilitation patients with SDB. The 
various diagnostic and prognostic cardiovascular measurements obtained from 
the exercise treadmill test were found to be related to SDB, with poorer 
exercise performance observed in SDB patients.(Maeder, 2012; Maeder, 
Münzer, et al.; Nanas et al., 2010) Furthermore, it was suggested that SDB 
treatment with CPAP could alleviate cardiovascular risks by reducing the 
levels of inflammatory markers, cholesterol and triglycerides, and improving 
the heart rate recovery post exercise, although this finding is still 
controversial.(Akashiba, Akahoshi, Kawahara, Majima, & Horie, 2005; 
Becker et al., 2003; Campos-Rodriguez et al., 2006; Ishida et al., 2009; 
Maeder, Ammann, et al.; Pepperell et al.; Surendra K. Sharma et al., 2011; 
Yokoe et al., 2003) Recent guidelines recommend treatment of SDB in 
patients with cardiovascular diseases. Nevertheless, the aforementioned 
studies were mostly performed on a relatively small number of patients who 
attended sleep clinics for evaluation of symptomatic SDB. As most of the 
SDB occurs in individuals from the undiagnosed community, the above 
findings might not be generalizable to the public. 
 





Figure 4. Proposed mechanism of SDB’s contribution to cardiovascular pathology. (Jaffe, Kjekshus, & Gottlieb, 2013)  




1.4 PREVALENCE OF SDB  
The reported prevalence rates of SDB have risen from 4-9% in the Wisconsin 
Sleep Cohort Study (Young et al., 1993) published 20 years ago to as high as 
17-50% in recent studies.(Heinzer et al., 2015b; P. E. Peppard et al., 2013) 
The HypnoLaus Study conducted between 2009 to 2013 found 23.4% of 
women and 49.7% of men in Switzerland had SDB.(Heinzer et al., 2015a) 
Sleep apnea syndrome (SAS), defined as SDB presented together with 
daytime sleepiness is found to be present in about 4% of men and 2% of 
women.(W. Lee et al., 2008) This observed increase in prevalence might be 
attributed to the global obesity epidemic and ageing population, as both are 
major risk factors for SDB.(M. Ng et al., 2014) Technical factors such as 
improved sensitivity of recording methods and new scoring criteria which is 
less stringent could also account for the rising prevalence.(BaHammam et al., 
2014) Despite its high prevalence, SDB remains under-recognized as up to 
95% of individuals with SDB remain undiagnosed,(Chen et al., 2015; S. 
Redline et al., 2014; Young, Evans, Finn, & Palta, 1997) indicating the lack of 
public awareness and knowledge. Furthermore, SDB subjects in the general 
population are usually asymptomatic or have unrecognized symptoms, 
meaning they are less likely to present to a healthcare provider for further 
evaluation.(Arnardottir, Bjornsdottir, Olafsdottir, Benediktsdottir, & Gislason, 
2016) Improved detection of this condition therefore depends on increased 
public awareness and effective diagnosis, so that timely detection and 
treatment can be provided.(Pancioli et al., 1998; Phua, Lim, Tay, & Aung, 
2013)  




1.5 CURRENT GOLD STANDARD: IN-LABORATORY 
POLYSMNOGRAPHY 
The current gold-standard for the diagnosis of SDB is a supervised in-
laboratory polysomnography performed overnight which records multiple 
channels including electroencephalography, electroocculography, 
electrocardiogram, airflow, oxygen saturation, respiratory movement, body 
position, pulse, chin and leg electromyogram.(W. Lee et al., 2008) Very often, 
polysomnography is coupled with video monitoring that provides technicians 
a more comprehensive view of the patients’ sleeping behaviors. Nevertheless, 
the use of polysomnography is limited by its cost and availability. The 
polysomnography is an expensive procedure, as it requires specialized 
equipment and trained sleep technicians to perform and analyze the study. 
There is also limited availability of sleep laboratories worldwide and this is 
illustrated in Table 2. The growing prevalence of SDB and resulting demand 
for sleep specialist consults and studies lead to increasingly long waiting lists 
which could potentially delay treatment.(Jennum & Riha, 2009) The waiting 
time for the diagnosis and treatment of SDB ranges from several months in the 
United States to as long as five years in the United Kingdom where healthcare 
is funded by the government.(Flemons, Douglas, Kuna, Rodenstein, & 
Wheatley, 2004) Furthermore, polysomnography is relatively time consuming, 
inconvenient and uncomfortable to the patients and could lead to poorer than 








Table 2. Sleep study rates and waiting time around the world. Reprinted with permission of the American Thoracic Society. 
Copyright © 2017 American Thoracic Society. Flemons, Douglas, Kuna, Rodenstein, & Wheatley. 2004. Access to Diagnosis and 
Treatment of Patients with Suspected Sleep Apnea. Am J Respir Crit Care Med Vol 169. pp 668–672. The American Journal of 
Respiratory and Critical Care Medicine is an official journal of the American Thoracic Society. 
Country Population No. of Sleep 
Labs 
No. of Sleep 
Beds 










Kingdom    
58,800,000 84 170 0.3 25,000 42.5 7–60 
Belgium 10,000,000 50 150 1.5 17,716 177.2 2 
 
Australia 18,970,000 65 244 1.3 53,500 282.0 3–16 
 
United States 280,000,000 1,292   1,170,000 427.0 2–10 
 
Canada 31,400,000 100 440 1.4 116,000 370.4 4-36 




1.6 SCREENING QUESTIONNAIRES 
Several questionnaires have been developed for preliminary screening to rule 
out those at low risk for SDB so that high risk individuals could be prioritized 
for further testing. This could lessen the burden of the rising demand for in-
laboratory polysomnography which has limited availability. The STOP-
BANG, Berlin Questionnaire (BQ) and Epworth Sleepiness Scale (ESS) are 
commonly used in sleep clinics to gather information to assist in the diagnosis 
and therapy of SDB. These questionnaires are easy to comprehend and are 
often self-administered; making them more readily acceptable by the general 
population for early risk stratification to facilitate further diagnostic testing. 
The different parameters assessed by each questionnaire are summarized in 
Table 3. 
 
The STOP-Bang questionnaire was developed in 2008 for use on surgical 
patients in preoperative clinics. It assesses the patient’s snoring, tiredness, 
presence of observed apneas and hypertension and four additional 
demographic queries.  
 
The BQ is a survey developed in 1996 in Germany by a group of respiratory 
and primary care physicians through consensus and initially validated in the 
primary care setting. The questionnaire consists of ten questions in three 
categories related to snoring behaviors, observed apneas, frequency of daytime 
sleepiness and the presence of obesity or hypertension. 
 




The ESS questionnaire is unlike the other two questionnaires as it does not 
specifically group individuals into their differing risks of SDB. Instead, it 
measures the chance an individual dozes off in eight commonly encountered 
situations. 
 
In 2016, a new screening tool, the NoSAS score was developed using a 
population-based cohort of 2121 subjects in Switzerland (HypnoLaus) and 
subsequently validated in a Brazilian cohort of 1042 subjects 
(EPISONO).(Marti-Soler et al., 2016b) The score assesses the individuals’ 
neck circumference, obesity, presence of snoring, age and sex. More about 






















x Snoring, loudness 
x Tiredness 
x Observed apneas 
x Hypertension 
x BMI (> 35 kg/m2) 
x Age (> 50 years old) 





x Snoring behaviors 
x Tiredness 
x Observed apneas 
x Hypertension 




x Chances of dozing off in eight different scenarios, 
usually during inactive periods spent sitting or 
lying down 
 
NoSAS score x Snoring 
x BMI (25 kg/m2 to 30 kg/m2) or BMI (≥ 30 kg/m2) 
x Age (> 55 years old) 
















1.7 PORTABLE DEVICES 
In order to circumvent the problem of limited availability of sleep laboratory, 
several outpatient portable sleep monitoring devices have been developed and 
validated for use against in-laboratory polysomnography, particularly among 
patients determined to have high pretest probability of SDB following 
comprehensive sleep evaluations.(Collop et al., 2007) According to the 
American Academy of Sleep Medicine (AASM), sleep studies are classified 
into four different levels based on the number of recorded channels and the 
circumstances they are used (Table 4).(C. L. Chai-Coetzer, Aiyappan, & 
Antic, 2014) In view of the increasing variety of portable devices available in 
the market, Collop et al recently proposed the SCOPER classification system 
to better categorize portable devices based on the type instead of the number 
of channels recorded.(Collop et al., 2011) Nevertheless, the four level 
classification system is still the most widely used today; hence further 
discussion will be based on this older and more established system. Type 1 
studies are the gold standard attended in-laboratory polysomnography which 
record at least seven channels. Type 2 portable polysomnography are as 
comprehensive as Type 1 studies, but with the exclusion of an attending 
technician. Type 3 portable monitoring measures at least four parameters 
whereas Type 4 records the minimum of either one or two channels. It is 
important to note that despite assessing the same physiological parameter, in-
laboratory polysomnography and the various portable devices may measure 
different signals or surrogates.(Collop et al., 2011) For instance, thermistors or 
nasal pressure transducers are typically used to monitor respiration in the 
laboratory whereas peripheral arterial tone may be measured in certain 




portable devices instead.  Therefore, it is difficult to make direct comparisons 
between the performance characteristics of the various types of studies.  
 
Among the various portable devices, Type 3 devices are most widely used in 
the outpatient setting and its use has been validated in patients with high pre-
test probability of SDB.(C. L. Chai-Coetzer et al., 2014; El Shayeb, Topfer, 
Stafinski, Pawluk, & Menon, 2014) These portable studies are cheaper, less 
time consuming, simpler to use, more accessible and convenient than the 
traditional polysomnography as the studies can be performed remotely at 
home. In the United States, commercial payors are encouraging the use of 
portable devices as the estimated savings amounts to USD$1140 for each 
medicare patient when compared to the gold-standard in-laboratory 
polysomnography.(Freedman, 2015) Moreover, portable monitoring might be 
the only viable option for diagnosing SDB in patients with exceptional 
circumstances such as immobility and critical illness, in which the 
performance of an in-laboratory polysomnography is not feasible.(Collop et 
al., 2007) In addition, the AASM Task Force recommends portable devices for 
the monitoring of response to SDB treatments other than CPAP in individuals 
who have already been diagnosed with SDB. This can contribute to the cost 
savings associated with disease management, as the purpose of the test would 
only be to look out for improvement to the severity of SDB.  
 
However, unattended portable monitoring may not be able to identify other 
kinds of sleep disorders and is more prone to data loss than in−laboratory 
polysomnography as the study is unattended.(Collop et al., 2007) 




Nevertheless, the cost associated with repeating a failed portable study is still 
lesser than one overnight in-laboratory polysomnography.(Freedman, 2015) 
The biggest drawback of portable monitoring, however, is the lack of 
electroencephalogram, which precludes the detection of arousals required for 
identifying hypopneas. Furthermore, the various sleep stages could not be 
scored and wakefulness could not be discriminated from sleep. Therefore, 
disease severity may be underestimated due to lower number of hypopneas 
identified and the apnea hypopnea index (AHI) is calculated using the total 
recording time instead of the actual sleep duration. Recent studies suggest that 
SDB during REM sleep is more detrimental to cardiovascular health than SDB 
occurring in non-REM sleep; hence the ability to differentiate the various 
sleep stages might have clinical significance. It was shown that REM AHI but 
not non-REM AHI was associated with prevalent and incident 
hypertension.(Mokhlesi et al., 2014) Nevertheless, a study which compared 
the performance between portable monitoring and polysomnography showed 
that the AHI obtained by both methods were consistent despite slight 
underestimation using the former.(Sopharat Vat et al., 2015) In addition, the 
same study also showed that the results obtained for a stratified general 
population and a high-risk cohort were compatible. Currently, there is 
insufficient evidence to indicate portable monitoring for general screening as 
previous studies have mostly been performed on cohorts with suspected SDB. 
Portable devices have been recommended for those with high pre-test 
probability to ensure that the post-test probability would be sufficiently high to 
be confident of the SDB diagnosis. The relationship between pre- and post-test 
probability takes into account the positive likelihood ratio (positive outcome) 




of each device. To achieve a given post-test probability, the positive likelihood 
ratio of a device has to increase as the pre-test probability decreases.(Collop et 
al., 2011) Therefore, a rise in the positive likelihood ratio from improved 
devices might be able to achieve high post-test probabilities in cohorts with 
lower pre-test probability. Hence, portable monitoring could potentially be 
used broadly in the general population to rapidly diagnose SDB with accuracy 
comparable to polysomnography in the future. 
 
Some groups have developed simplified diagnostic algorithms to help identify 
patients with SDB quickly. These models are two-staged as they combine 
results from the various SDB screening questionnaires and portable sleep 
studies. Results show that such models have high predictive powers in primary 
care patients and the long-term patient outcome and adherence to CPAP 
treatment was comparable to those receiving the gold standard in-laboratory 













Table 4. The four level sleep study classifications  
 
Device Description Advantages/Disadvantages 
Type 1 Attended in-laboratory 
polysomnography which records 
at least seven channels and body 
position sensor(C. L. Chai-





electrocardiogram, airflow, blood 
oxygenation, respiratory effort 
and chin electromyography) 
 
x Gold standard 
x Well controlled 
x Allows identification of 
other sleep disorders 
x Expensive 
x Limited availability 
x Inconvenient 
x Uncomfortable, leading 
to poor sleep quality 
Type 2 Unattended portable 
polysomnography which records 
at least seven channels and 
optional body position sensor (C. 





electrocardiogram, airflow, blood 
oxygenation, respiratory effort 
and chin electromyography) 
 
x Portable device that 
provides the most data 
x Cheaper than Type 1 
study 
x Better sleep quality 
x Can overestimate/ 
underestimate disease 
severity(Bruyneel et al., 
2011) 
x Loss of data 
 
Type 3 Unattended portable study that 
records at least four parameters 
(Recommended minimal 
parameters include: 
electrocardiogram, airflow, blood 
oxygenation and respiratory 
effort)(Collop et al., 2007) 
x Good predictive power in 
selected population 
x Inexpensive 
x Better sleep quality 
x Cannot differentiate wake 
from sleep 
x Underestimation of 
disease severity  
x Loss of data 
 
Type 4 Unattended portable study that 
records either one or two 
channels (usually airflow and 
blood oxygenation)(C. L. Chai-
Coetzer et al., 2014) 
x Simplest  
x Inexpensive 
x Better sleep quality 
x Cannot differentiate wake 
from sleep 
x Underestimation of 
disease severity  
x Loss of data 
x Requires more validation 




1.8 AIMS  
This thesis consists of a series of studies that aim to understand the prevalence 
and awareness of SDB in Singapore, and to validate the usefulness of several 
screening questionnaires in predicting SDB within the local multiethnic 
community. The ability of these questionnaires to predict exercise fitness in a 
specific cohort of patients attending cardiac rehabilitation was also 
investigated. Lastly, we further examined the association between SDB and a 
selected panel of cardiovascular risk markers among community individuals 
and explored the feasibility of incorporating SDB screening routinely into 














  CHAPTER 2  
 28 
CHAPTER 2:  MATERIALS AND METHODS 
2.1 INTRODUCTION TO THE DIFFERENT STUDIES 
For chapters three to five, the same pool of participants was obtained from 
study subjects in the Singapore Health Study 2012 (SH2012). The SH2012 
was a national cross-sectional study conducted between August 2012 and 
March 2013 with the aim of measuring the prevalence of major non-
communicable disease such as diabetes mellitus and hypertension. In 2010, 
the total population of Singapore citizens and permanent residents was 3.77 
million.(B. D. Kent et al., 2013) This comprised 74.3% Chinese, 13.3% 
Malays, 9.1% Indians and 3.3% other ethnicities. A subset of this population-
based cohort was invited to participate in the present series of studies. The 
SDB screening questionnaires and portable sleep tests were completed and 
performed in the participants’ home whereas follow-up interviews were 
conducted over the phone by trained interviewers.  
 
The study in chapter six was conducted at the Singapore Heart Foundation 
Heart Wellness Center, which is a national institution in Singapore that runs a 
late-phase, community-based Heart Wellness Program. The late-phase cardiac 
rehabilitation comprises a lifetime maintenance phase in which physical 
fitness and additional risk-factor reduction are emphasized. The Singapore 
Heart Foundation Heart Wellness Centre accepts referral for primary (high 
cardiovascular risk; hypertension, diabetes, hyperlipidemia and obesity) and 
secondary (coronary artery disease, valvular heart disease, cardiac arrhythmias 
and stable chronic heart failure) cardiovascular disease prevention. Patients 
enrolled in this late-phase cardiac rehabilitation program were invited to 
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participate in the study. The 6-minute walk test (6MWT) was conducted by a 
trained physiotherapist at the cardiac rehabilitation facility. 
 
Participants for the Sleep Apnea and Vascular Risk Evaluation (SAVE) study 
in chapter seven were recruited from the Wellness Center of the University-
affiliated National University Hospital in Singapore. The Wellness Center is a 
private health screening centre offering a range of health screening packages 
that detect for common chronic diseases such as heart disease, stroke, 
hypertension and diabetes. Participants of these health screening packages 
were self-referred community individuals and more than half of them consist 
of foreigners from neighboring Asian countries who visit Singapore for health 
screening purposes. Only those enrolled in the cardiovascular health screening 
package, which included laboratory and exercise treadmill tests, were 
approached for recruitment into the study. The laboratory and exercise 
treadmill tests and the screening questionnaires were completed at the 
Wellness Center. The overnight sleep tests were conducted at the participants’ 
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2.2 STUDY DESIGN AND SAMPLE FROM SH2012 
The sampling methodology of SH2012 has been illustrated previously.(Win et 
al., 2015) Briefly, the inclusion criteria were citizens or permanent residents 
aged 18 to 79 years as of July 2012. Exclusion criteria were mental 
retardation, pregnancy, stroke resulting in loss of speech or bedridden status. 
A total of 14,200 households were selected randomly from a database 
maintained by the Department of Statistics, Singapore. From the households 
enumerated, 6000 residents were invited to participate in the study. Malays 
and Indians were oversampled to ensure sufficient sample size for reliable 
prevalence estimates in these minority groups, resulting in a final sample 
composed of 35% Chinese, 35% Malays, 25% Indians and 5% other 
ethnicities. A total of 2345 individuals agreed to participate, yielding an 
overall response rate of 40%. Participants underwent interviews on 
socioeconomic factors, lifestyle and medical history as well as screening tests 
for diabetes, blood lipids, urinary proteins and anthropometric measurements. 
Data for analysis were available for 2329 participants; out of which 1984 
completed the Pittsburg Sleep Quality Index, from which they were further 
assigned either a snorer or non-snorer status. All snorers and 500 non-snorers 
were randomly selected and contacted via phone to take part in a home-based 
sleep test. Only 332 of the randomly selected 500 non-snorers were contacted 
due to logistic constraints. The National Healthcare Group Domain Specific 
Review Board approved the research protocol (reference: F/2014/00606), and 
informed consent was obtained from all participants. 
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2.3 QUESTIONNAIRES 
Prior to the sleep test, all participants were handed screening questionnaires 
for self-administration, which can also be accessed online.(Berlin 
Questionnaire (for sleep apnea) 
http://www.sleepapnea.org/assets/files/pdf/berlin-questionnaire.pdf. Accessed 
July 12; Peter Y. Hahn, 2007) Demographics such as BMI, age, neck and 
waist circumferences were recorded by the technicians.  
 
2.3.1 STOP-BANG Questionnaire 
The STOP-BANG questionnaire consists of four simple yes/no questions 
related to loudness of snoring (S), daytime tiredness (T), observed apneas (O) 
and high blood pressure (P) and four additional demographic queries which 
include BMI >35kg/m2 (B), age >50 years (A), neck circumference >40cm  
(N) and male gender (G). Subjects were classified as high risk for SDB if they 
score positive to at least three questions. Table 5 lists the specific questions 
assessed by the STOP-BANG questionnaire. 
 
2.3.2 Berlin Questionnaire 
The BQ divides its questions into three categories. In category one, high risk 
was defined as positive responses to two or more questions related to snoring 
and observed apneas. In category two, high risk was defined as positive 
responses to two or more to questions related to daytime sleepiness and 
drowsy driving. In category three, high risk was defined as a history of 
hypertension (>140/90mmHg) and/or obesity (BMI >30kg/m2). High risk for 
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SDB was defined as persistent or frequent symptoms in two out of the three 
categories. Table 6 lists the specific questions assessed by the BQ. 
 
2.3.3 Epworth Sleepiness Scale  
ESS measures the chances (from a scale of zero to three) of an individual 
dozing off in eight commonly encountered day-to-day situations, mostly 
during periods of inactivity. From a total score of 24, scores greater than 10 
were classified as at risk of excessive day time sleepiness.(El-Sayed, 2012; 
Johns, 1991) Table 7 lists the specific questions asked in the ESS. 
 
2.3.4 NoSAS Score 
The NoSAS score ranges from zero to 17, and assigns different points for the 
various assessed parameters: neck circumference >40cm (N), obesity defined 
as BMI of 25 kg/m2 to <30 kg/m2 or ≥30kg/m2 (O), snoring (S), age >55 years 
(A), and male sex (S). A score of at least eight was defined as high risk of 
SDB. Table 8 lists the specific questions assessed by the NoSAS score. 
 
2.3.5 InterHeart Risk Score 
The InterHeart Risk score was derived from a large multi−ethnic case–control 
study involving 19,470 individuals in 52 countries which determines their 
cardiovascular risk profiles by evaluating their demographics, medical history 
and existing lifestyles.(McGorrian et al., 2011) The non-laboratory-based 
version of the questionnaire was used and it included age, sex, smoking status, 
diabetes mellitus, high blood pressure, family history of heart disease, waist-
to-hip ratio, psychosocial factors, diet, and physical activity.  A score of less 
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than 10, between 10 to 15 and above 15 were classified as low, moderate and 
high risk for future heart attack, respectively. Table 9 lists the specific 
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1) Do you snore loudly (louder than talking or loud 
enough to be heard through closed doors)? 
x Yes/No 
2) Do you often feel tired, fatigued, or sleepy during 
daytime? 
x Yes/No 
3) Has anyone observed you stop breathing during your 
sleep? 
x Yes/No 
4) Do you have or are you being treated for high blood 
pressure? 
x Yes/No 
5) BMI > 35 kg/m2? 
x Yes/No 
6) Age >50 years old? 
x Yes/No 
7) Neck circumference >40 cm? 
x Yes/No 
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1) Do you snore? 
a) Yes (1) 
b) No (0) 
c) Do not know/refused (0) 
2) If you snore, your snoring is: 
a) Slightly louder than breathing (0) 
b) As loud as talking (0) 
c) Louder than talking (1) 
d) Very loud; can be heard in adjacent rooms 
(1) 
e) Do not know/refused (0) 
3) How often do you snore? 
a) Nearly every day (1) 
b) 3 to 4 nights per week (1) 
c) 1 to 2 nights per week (0) 
d) 1 to 2 nights per month (0) 
e) Never or nearly never/do not know (0) 
4) Has your snoring ever bothered other people? 
a) Yes (1) 
b) No (0) 
c) Do not know/refused (0) 
5) Has anyone noticed that you quit breathing during 
your sleep? 
a) Nearly every day (2) 
b) 3 to 4 times a week (2) 
c) 1 to 2 times a week (0) 
d) 1 to 2 times a month (0) 
e) Never or nearly never/do not know/refused 
(0) 
Category 2 
6) How often do you feel tired or fatigued after your 
sleep? 
a) Nearly every day (1) 
b) 3 to 4 times a week (1) 
c) 1 to 2 times a week (0) 
d) 1 to 2 times a month (0) 
e) Never or nearly never/do not know/refused 
(0) 
7) During your waking time, do you feel tired, 
fatigued, or not up to par? 
a) Nearly every day (1) 
b) 3 to 4 times a week (1) 
c) 1 to 2 times a week (0) 
d) 1 to 2 times a month (0) 
e) Never or nearly never/do not know/refused 
(0) 
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8) Have you ever nodded off or fallen asleep while 
driving a vehicle? 
a) Yes (1) 
b) No (0) 
c) Do not know/refused (0) 
9) If yes, how often does it occur? 
a) Nearly every day (1) 
b) 3 to 4 times a week (1) 
c) 1 to 2 times a week (0) 
d) 1 to 2 times a month (0) 
e) Never or nearly never/do not know/refused 
(0) 
Category 3 
10) Do you have high blood pressure? 
a) Yes (1) 
b) No (0) 
c) Do not know/refused (0)  
11) BMI, kg/m2? 
a) >30 (1) 
b) ≤30 (0) 
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How likely are you to doze off or fall asleep in the 
following situations, in contrast to feeling just tired? This 
refers to your usual way of life in recent times. Even if you 
have not done some of these things recently try to work out 
how they would have affected you. Use the following scale 
to choose the most appropriate number for each situation: 
 
0 = no chance of dozing 
1 = slight chance of dozing 
2 = moderate chance of dozing 
3 = high chance of dozing 
Total score (0–24) 
 
1) Sitting and reading 
2) Watching television 
3) Sitting inactive in a public place (e.g. a theater or 
meeting) 
4) As a passenger in a car for an hour without a break 
5) Lying down to rest in the afternoon whenever 
possible 
6) Sitting and talking to someone 
7) Sitting quietly after a lunch without alcohol 
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Table 8. Questions specified in the NoSAS score. 
Questionnaire Questions 
NoSAS Score 1) Neck circumference >40 cm (4) 
2) BMI 25 kg/m2 to 30 kg/m2 (3) 
3) BMI ≥30 kg/m2 (5) 
4) Snoring (2) 
5) Age >55 years (4) 
6) Male sex (2) 
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1) Age and gender 
a) Male ≥55 years old (2) 
b) Female ≥65 years old (2) 
2) Past Medical History 
a) Diabetes (6) 
b) High Blood Pressure (5) 
3) Either/both biological parents had a heart attack? 
(4) 
4) Which best describes your history of tobacco use 
a) Never (0) 
b) Former; >12 months of not smoking (2) 
c) Current 
i. 1-5/day (2) 
ii. 6-10/day (4) 
iii. 11-15/day (6) 
iv. 16-20/day (7) 
v. >20/day (11)  
5) Over the past 12 months what has been your typical 
exposure to other peoples smoke? 
a) <1h/week or no exposure (0) 
b) ≥1h/week (2) 
6) How often have you felt stress in the past year 
a) Never Experienced Stress (0) 
b) Some Period of Stress (0) 
c) Several Periods of Stress (3) 
d) Permanent Stress (3) 
7) During the past twelve months, you felt sad, blue, or 
depressed for two weeks or more in a row (3) 
8)  How active are you during your leisure time 
a) Mainly sedentary (e.g. sitting, reading, watching 
television) (2) 
b) Mild exercise, minimal effort (eg. yoga, archery, 
sport fishing, easy walking) (2) 
c) Moderate exercise (eg. walking, bicycle riding, 
or light gardening at least 4 hours per week) (0) 
d) Strenuous exercise (heart beats rapidly e.g. 
running/jogging, football, vigourous swimming) 
(0) 
9) You eat salty food or snacks one or more times a 
day (1)  
10) You eat deep fried foods or snacks or fast foods 3 or 
more times a week (1) 
11) You do not eat fruit one or more times daily (1) 
12) You do not eat vegetables one or more times daily 
(1)   
13) You eat meat and/or poultry 2 or more times daily 
(2) 
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14) Waist to Hip Ratio   
a) <0.873 (0) 
b) 0.873-0.963 (2) 
c) ≥0.964 (4) 
(Numbers) refers to the points allocated for each answer. 
 
  
  CHAPTER 2  
 41 
2.4 HOME-BASED SLEEP TEST 
All recruited participants were scheduled for the sleep test regardless of their 
results on the screening questionnaires. The sleep tests were conducted using a 
United States Food and Drug Administration-approved type 3 portable 
monitor device (Embletta Gold; Natus Medical Incorporated, Pleasanton, CA, 
USA) (Figure 5) validated for use against in-laboratory polysomnography.(S. 
S. Ng et al., 2010) The reported sensitivity and specificity ranged from 0.853 
to 0.924 and 0.857 to 0.957, respectively.(S. S. Ng et al., 2010) The portable 
diagnostic device was used to record nasal airflow (nasal pressure transducer), 
thoracic and abdominal movements (respiratory inductance plethysmography 
belts) and arterial oxygen saturation (pulse oximetry). A Registered 
Polysomnographic Technologist who was blinded to the characteristics of the 
recruited participants manually scored the tracings. The overnight sleep 
studies were all graded for quality based on the criteria which were developed 
after a review of published scoring guidelines.(S. Redline et al., 1998) At least 
4h of interpretable signals were required for inclusion into analysis. All 
tracings graded as poor were considered as failed studies and excluded from 
the analysis. The primary measure was AHI and respiratory events were 
scored according to both the 2012 and 2007 American Academy of Sleep 
Medicine (AASM) scoring criteria.(Berry et al., 2012; Iber, Ancoli-Israel, 
A.L., & Quan) Apneas were defined as a ≥90% reduction in airflow from the 
baseline value for at least 10s, and were further classified as obstructive if 
paradoxical thoraco-abdominal movement was observed, and as central if 
there was no thoraco-abdominal movement. Hypopneas were defined as a 
≥30% reduction in airflow for at least 10s in conjunction with either an 
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oxyhemoglobin desaturation of ≥3% (2012 AASM criteria) or ≥4% (2007 
AASM criteria). The AHI was then calculated as the number of apneas and 
hypopneas per hour of recording time. The 2012 AASM criterion is the most 
current guidelines and thus is used for primary analysis. Otherwise stated, the 
AHI stated in this series of studies represents the index scored using 2012 
AASM criteria. The index scored according to the 2007 AASM criteria is 
distinguished from the 2012 AASM criteria as AHI4. SDB severity was 
defined using thresholds of AHI ≥5, 15, and 30 events per hour to represent 
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Figure 5. Type 3 portable monitor device (Embletta Gold; Natus Medical 
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2.5 IMPORTANT DEFINITIONS 
Sleep disordered breathing (SDB) is an umbrella term for different types of 
nocturnal respiratory disorders including obstructive sleep apnea, central sleep 
apnea and mixed apnea. Table 1 summarizes these three types of SDB. Sleep 
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2.6 PHONE INTERVIEW ON SDB AWARENESS  
Participants were subsequently contacted via phone by trained interviewers to 
complete a questionnaire assessing awareness and knowledge of SDB. To 
ensure good response, calls were made on at least three different attempts, on 
all days of the week including weekends and during different times of the day 
including evenings. If there was no response after three call-back attempts, a 
short messaging service message was sent to participants’ mobile phone 
numbers to arrange for a suitable contact time. Singapore is a multi-ethnic 
country with much of the population speaking English, but other official 
languages include Chinese Mandarin, Malay and Tamil. The trained 
interviewers conducted the survey in the participants’ native language 
whenever possible. The questionnaire used assessed a broad range of 
knowledge including that pertaining to the definition, risk factors, signs and 
symptoms, consequences, perception of importance of treatment and treatment 
modalities of SDB. The questions asked are detailed in Table 10. All the 
responses were vetted and grouped together into common themes. Answers 
considered correct for the definition, risk factors, symptoms and consequences 
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Table 10. Questions assessing knowledge of SDB 
 
No. Question 
1 Have you ever been diagnosed with SDB? 
Yes (Go to Question 2) 
No (Go to Question 3) 
2 If yes, are you on any sort of treatment? If not on treatment, why not? 
3 Are you aware of a condition such as SDB? 
Yes (Go to Question 4) 
No (Go to Question 5) 
4 If yes, what is SDB? 
5 Do you know of risk factors for SDB? 
Yes (Go to Question 6) 
No (Go to Question 7) 
6 If yes, what are the risk factors for SDB that you know of? 
7 Are you aware of the symptoms of SDB? 
Yes (Go to Question 8) 
No (Go to Question 9) 
8 If yes, what are the symptoms of SDB that you know of? 
9 Are you aware of the health consequences of SDB? 
Yes (Go to Question 10) 
No (Go to Question 11) 
10 What are some of the health consequences of SDB that you know of? 




12 Are you aware of any treatment options for SDB? 
Yes (Go to Question 13) 
No (Go to Question 14) 
13 If yes, what are the treatment options for SDB that you know of? 
For those diagnosed with SDB in the portable sleep study 
14 Now that you have been told you have SDB, are you likely to seek 
further medical help and advice? 
Yes 
No (Go to Question 15) 
Maybe (Go to Question 15) 
15 If no / maybe, why not? 
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Table 11. Accepted answers for survey on knowledge of SDB 
 
Variable Accepted Answers 
Definition 1. Blockage of air pipe during sleep 
2. Breathing stops during sleep 
3. Breathing interrupted during sleep 
4. Choking during sleep 
5. Dyspnoea during sleep 
6. Desaturation or lack of oxygen during sleep 
7. Snoring during sleep 
8. Awakening during sleep 
Risk factors 1. Obesity 
2. Thick neck 
3. Age 




8. Male gender 
9. Narrow airway due to anatomical factors (E.g. Big 
tongue, nose problem) 
10. Pre-existing lung conditions 
11. Heart disease 
12. Hypertension 
Symptoms 1. Excessive sleepiness 
2. Snoring, choking or stop breathing during sleep 
3. Unrefreshing sleep / Fatigue 
4. Fall asleep at undesirable times 
5. Dry mouth 
6. Lack of concentration 
7. Frequent awakening 
8. Death during sleep 
9. Difficulty sleeping 
10. Headaches 
Consequences 1. Cardiovascular morbidity 
2. Feeling tired 
3. Death during sleep 
4. Increased overall mortality 
5. Excessive daytime sleepiness 
6. Hypertension 
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2.7 SIX-MINUTE WALK TEST 
The guidelines for the 6MWT are specified by the committee from the 
American Thoracic Society.("ATS statement: guidelines for the six-minute 
walk test," 2002) Briefly, participants were instructed by a trained 
physiotherapist to walk back and forth on a level, hard surface for six minutes 
at their own pace. The test measures the total distance travelled by each 















  CHAPTER 2  
 49 
2.8 LABORATORY TESTS 
Blood was drawn in the morning at the Wellness Center after an overnight fast 
of at least 10h. In all participants, the levels of hs−CRP, uric acid, fasting 
plasma glucose, total cholesterol, triglycerides, high-density lipoprotein 
(HDL)−cholesterol, low−density lipoprotein (LDL)−cholesterol, urea, 
creatinine, chloride, calcium, phosphate, albumin, bilirubin, aspartate 
aminotransferase, alanine aminotransferase, alkaline phosphatase, full blood 
count, thyroid stimulating hormone, thyroxine, and glycosylated hemoglobin 
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2.9 EXERCISE TREADMILL TEST  
The exercise treadmill test was performed using the standard Bruce protocol 
and terminated when participants achieved the target heart rate (85% of 
predicted maximum heart rate) or developed ischemic symptoms and/or 
signals on the electrocardiography.(Nishime, Cole, Blackstone, Pashkow, & 
Lauer, 2000; Vivekananthan, Blackstone, Pothier, & Lauer, 2003) The 
subjects were encouraged not to tightly grasp the rails. During each exercise 
stage and recovery stage, symptoms, blood pressure, heart rate, cardiac 
rhythm, and exercise workload in metabolic equivalents (METs, automatically 
estimated from the treadmill speed and grade) were recorded. An ischemic 
ST−segment response was defined as at least 1mm of horizontal or 
downsloping ST−segment depression 80 milliseconds after the J point. 
 
The treadmill tracings were analyzed according to the published standard 
method.(Nishime et al., 2000; Vivekananthan et al., 2003) Following peak 
exercise, participants walked for a 2−minute cool−down period. Heart rate 
recovery at 1 minute was defined as the difference between heart rate at peak 
exercise and at 1 minute later, and was considered abnormal when it was ≤12 
per min. Likewise, heart rate recovery at 2, 3, 4, and 5 minutes were defined 
as the difference between heart rate at peak exercise and the respective time 
intervals. Chronotropic incompetence was considered present if less than 80% 
of the participant's heart rate reserve (calculated as 220 − age − resting heart 
rate) was used at peak exercise. The Duke treadmill exercise score was 
calculated as previously described: [duration of exercise (in minutes)] − [5 × 
maximal ST-segment deviation during or after exercise (in millimeters)] − [4 
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CHAPTER 3: PREVALENCE AND AWARENESS OF SDB IN 
SINGAPORE 
3.1 INTRODUCTION 
Previous studies on the prevalence of SDB were performed in a predominantly 
white population and may not be generalizable to Asians. Similar to the West, 
landmark studies of SDB prevalence in Asians were performed more than a 
decade ago.(Ip et al., 2001; Kim et al., 2004; Udwadia, Doshi, Lonkar, & 
Singh, 2004) Hence, there is a need for updated SDB prevalence rates in Asia. 
In addition, the impact of ethnicity on SDB within Asia remains 
unknown.(Ralls & Grigg-Damberger, 2012; Villaneuva, Buchanan, Yee, & 
Grunstein, 2005) There are limited community-based studies looking at SDB 
prevalence across ethnic groups, with even fewer studies including Asians. 
Some studies have found that SDB prevalence varies by ethnicity (Ancoli-
Israel et al., 1995; Pranathiageswaran, Badr, Severson, & Rowley, 2013) while 
others reported no ethnic inequalities.(Baldwin et al., 2010) With regards to 
the awareness of sleep apnea, previous studies focused mainly on health 
professionals and medical students (Ozoh, Iwuala, Desalu, Ojo, & Okubadejo, 
2015; S. Sharma & Srijithesh, 2013) and the general population of Caucasian 
(Walker, Saltman, Colucci, & Martin, 2010) and Black (Shaw et al., 2012) 
subjects. To our understanding, no study has been performed on assessing the 
awareness and knowledge of SDB in an Asian population. Therefore, there is 
a lack of data looking at both the prevalence variation and awareness of SDB 
across different Asian ethnicities. 
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Singapore is an ethnically diverse population predominantly composed of 
Chinese, Malays and Indians. The aim of this study was to estimate the SDB 
prevalence among Singaporeans in the community and to quantify the 
distribution of prevalence rates among the three major ethnic groups. In 
addition, as weight gain parallels increasing SDB severity, we examined if 
ethnicity remained a predictor for SDB after adjustment for BMI if differential 
rates were found. Lastly, awareness of SDB in the local community and the 
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3.2 MATERIALS AND METHODS 
3.2.1 Study Subjects 
Participants were obtained from a subset of study subjects enrolled in the 
SH2012 study who completed the Pittsburg Sleep Quality Index. A total of 
256 participants out of the 336 snorers and 332 non-snorers who were 
contacted agreed to undergo the home-based sleep test. 
 
3.2.2 Anthropometry 
To account for changes since the 2012 health screening, anthropometric 
measurements such as weight, neck and waist circumferences were reassessed. 
 
3.2.3 Epworth Sleepiness Scale 
Prior to the sleep test, participants completed the ESS to find out the 
prevalence of SAS, which was defined as an ESS score of ≥10, and AHI of 
≥5. 
 
3.2.4 Home-Based Sleep Test 
To investigate the prevalence of SDB, sleep testing was performed using a 
type 3 portable monitoring device between October 2014 and May 2015. Data 
was scored according to both the 2012 (scoring hypopneas with desaturation 
of ≥3%) and 2007 (scoring hypopneas with desaturation of ≥4%) AASM 
scoring criteria. Mild-to-severe, moderate-to-severe and severe SDB were 
defined as an AHI ≥5, 15, and 30 events per hour, respectively. The 
participants were also asked if they had received prior physician diagnosis of 
SDB. 
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3.2.5 Phone Interview on SDB Awareness 
A follow-up survey after the sleep test was conducted to assess the 
participants’ knowledge of SDB. 
 
3.2.6 Statistical Analysis 
Due to the complex sampling scheme, survey weights were implemented to 
account for differential probabilities in selection of households and response 
rates. Post-stratification weights were computed based on ethnicity, age and 
gender. Overall sample weights were then applied on the data to be 
representative of Singapore’s general population. Demographics for the 
SH2012 sample and sleep study data were calculated directly from respective 
samples and repeated with application of sample weights. For BMI, Asian cut-
off points were used to define overweight and obese categories according to 
the recommendation by WHO.("Appropriate body-mass index for Asian 
populations and its implications for policy and intervention strategies," 2004) 
All SDB and SAS prevalence rates were estimated after application of sample 
weights. We summarized data as means and standard deviations for 
continuous variables and percentages for categorical variables. Comparisons 
between groups were done with the t test, chi-squared test and analysis of 
variance. Univariate (unadjusted) and multiple logistic regression models 
(adjusted for confounders) were applied to assess the association between 
ethnicity and moderate-to-severe SDB. Univariate and multivariate analysis 
were applied to evaluate predictors of low knowledge. All statistical tests were 
two-sided and performed at a 5% level of significance (P <0.05). The 
statistical programs used were R V.3.2.1 and IBM SPSS Statistics version 23.  
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3.3 RESULTS 
3.3.1 Characteristics of the SH2012 Sample 
Table 12 shows the demographics of the SH2012 subjects (n =2329) 
categorized by different ethnic groups. The mean BMI for Chinese, Malays 
and Indians were 23.3 ± 0.1 kg/m2, 26.0 ± 0.2 kg/m2 and 25.4 ± 0.2 kg/m2, 
respectively (P <0.001). Malays had the highest prevalence (34.9%) of obesity 
defined as BMI >27.5 kg/m2 while Chinese had the lowest prevalence 
(14.1%). The prevalence of smoking (28.6%) and self-reported snoring 
(19.8%) was highest among the Malays. The corresponding population-level, 
weighted estimates of Table 12 are shown in Supplementary Table S1.  
 
Figure 6 depicts the number of individuals recruited at each stage and the 
corresponding response rates. There were 336 snorers and 1648 non-snorers as 
classified by the Pittsburg Sleep Quality Index. All snorers and 332 non-
snorers were contacted, out of which 37.4% (n=137) of the snorers and 35.8% 
(n=119) of the non-snorers agreed to participate in the home-based sleep test. 
Fourteen out of the total 256 (5.5%) sleep studies were rejected due to 
insufficient recording time of <4h, leaving a total of 242 sleep studies in the 
final analysis. There were no significant differences with respect to age, sex 
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Sex      
Men 427 (53.2) 356 (44.0) 284 (47.7) 63 (52.1) 0.002 
Age, years 45.2 ± 0.6 41.6 ± 0.5 41.5 ± 0.6 41.4 ± 1.1 < 0.001 
Age group      
21-40 years 310 (38.7) 366 (45.2) 296 (49.7) 54 (44.6) < 0.001 
41-60 years 339 (42.2) 363 (44.9) 237 (39.8) 60 (49.6)  
≥ 61 years 153 (19.1) 80 (9.9) 63 (10.5) 7 (5.8)  
BMI, (kg/m2)† 23.3 ± 0.1 26.0 ± 0.2 25.4 ± 0.2 24.7 ± 0.4 < 0.001 
BMI category      
BMI < 23 
kg/m2 
388 (51.7) 240 (31.9) 168 (29.8) 44 (37.6) < 0.001 
BMI = 23-27.5 
kg/m2 
257 (34.2) 249 (33.2) 239 (42.5) 48 (41.0)  
BMI > 27.5 
kg/m2 
106 (14.1) 262 (34.9) 156 (27.7) 25 (21.4)  
Diabetes† 57 (7.2) 73 (9.2) 77 (13.0) 3 (2.5) < 0.001 
Hypertension† 134 (16.9) 129 (16.3) 89 (15.0) 17 (14.2) 0.74 
Smokers 131 (16.3) 232 (28.6) 103 (17.3) 20 (16.5) < 0.001 
Drinkers      
Never 307 (38.3) 729 (90.0) 351 (58.9) 52 (43.0) < 0.001 
Occasionally 403 (50.2) 60 (7.4) 190 (31.9) 53 (43.8)  
Frequent 92 (11.5) 21 (2.6) 55 (9.2) 16 (13.2)  
Unemployed*† 16 (2.0) 19 (2.4) 15 (2.5) 4 (3.3) 0.81 
Snorers† 108 (15.5) 137 (19.8) 69 (12.6) 22 (17.4) 0.039 
Data are presented as mean ± standard deviation or number (percentage).  
BMI, body mass index. 
*Persons are counted as unemployed, if they are not working, but are actively 
looking and available for work. 
† 2182, 2299, 2298, 2319 and 1984 subjects completed the baseline 
examination for the variables of BMI, Diabetes, Hypertension, Unemployment 






























Figure 6. Basic flow chart of the study. Fourteen studies were rejected in view 






2010 Population of Singapore: 3,771,721 
Age 21 – 79 years: 2,733,189 
1984 of 2329 randomly selected participants 
Screened through Pittsburgh Sleep Questionnaire 
Response rate 85.1% 
119 Home-based sleep studies 
242 successful studies 
1648 non-snorers 336 snorers 
 All contacted (336) Randomized 500 
Contacted 332 
8 studies rejected 6 studies rejected 
137 Home-based sleep studies 
129 successful studies 
 
113 successful studies 
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3.3.2 Baseline of Participants 
Table 13 summarizes the baseline characteristics of the 242 participants whose 
data were included in the final analysis. One hundred and twenty-two (50.4%) 
participants were male and the participants had a mean age of 48.3 + 14.0 
years and a mean BMI of 26.2 ± 5.0 kg/m2. Using Asian BMI cut-off points to 
define the overweight and obese categories,("Appropriate body-mass index for 
Asian populations and its implications for policy and intervention strategies," 
2004) 99 (40.9%) participants were overweight with a BMI of 23–27.5 kg/m2 
and 81 (33.5%) participants were obese with a BMI of >27.5 kg/m2. The 
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Table 13. Baseline characteristics of the 242 study participants who 




  Men 122 (50.4) 
Age, years 48.3 + 14.0 
Age group  
  21-40 years 76 (31.4) 
  41-60 years 121 (50%) 
  ≥ 61 years 45 (18.6%) 
Ethnic group  
  Chinese 93 (38.4) 
  Malays 78 (32.2) 
  Indians 55 (22.7) 
  Others 16 (6.6) 
BMI, (kg/m2) 26.2 ± 5.0 
BMI category  
  BMI < 23 kg/m2 62 (25.6) 
  BMI = 23-27.5 kg/m2  99 (40.9) 
  BMI = 27.6-30 kg/m2 41 (16.9) 
  BMI = 30.1-35 kg/m2 26 (10.7) 
  BMI > 35 kg/m2 14 (5.8) 
Neck circumference, cm 36.4 ± 4.1 
Waist circumference, cm 91.8 ± 12.7 
Diabetes 21 (8.7) 
Hypertension 39 (16.1) 
Smokers 44 (18.2) 
Drinkers  
  Never 146 (60.3) 
  Occasionally 82 (33.9) 
  Frequent 14 (5.8) 
Epworth Sleepiness Scale score 6.9 ± 4.2 
Data are presented as mean ± SD or number (percentage). 
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3.3.3 Home-Based Sleep Test  
Table 14 shows the demographic and sleep test data of those with AHI <15 
and AHI ≥15. Age, BMI, neck circumference and waist circumference were 
significantly higher in those with AHI ≥15 compared to those with AHI <15. 
The prevalence of male sex, hypertension and self-reported snorers were also 
higher in the group with AHI ≥15. No difference was noted in the ESS scores 
between the two groups. The mean AHI (7.2 ± 0.3 versus 31.3 ± 2.0), oxygen 
desaturation indices (4.9 ± 0.3 versus 24.5 ± 1.8), and arterial oxygen 
saturation (SpO2) were also higher in the group with AHI ≥15. The 
corresponding population-level, weighted estimates of Table 14 are shown in 
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Table 14. Demographic and sleep test data of the 242 study participants by 
AHI cut-off 15  
 
 AHI < 15 
(N=175) 
AHI ≥ 15 
(N=67) 
P-value 
Sex    
  Men 79 (44.6) 44 (65.7) 0.005 
Age, years 45 ± 1.08 53.2 ± 1.39 < 0.001 
BMI, kg/m2 25.3 ± 0.3 28.3 ± 0.7 < 0.001 
Neck circumference, cm 35.5 ± 0.3 38.7 ± 0.4 < 0.001 
Waist circumference, cm 89.5 ± 0.9 97.9 ± 1.6 < 0.001 
Diabetes 12 (16.9) 9 (13.4) 0.18 
Hypertension 21 (12.2) 18 (26.9) 0.01 
Smokers 30 (17.1) 14 (20.9) 0.62 
Drinkers    
  Never 102 (58.3) 44 (65.7) 0.33 
  Occasionally 64 (36.6) 18 (26.9)  
  Frequent 9 (5.1) 5 (7.5)  
Snorers 84 (48.0) 45 (67.2) 0.01 
AHI  7.2 ± 0.3 31.3 ± 2.0 < 0.001 
ODI 4.9 ± 0.3 24.5 ± 1.8 < 0.001 
Baseline SpO2, % 95.0 ± 0.1 93.7 ± 0.2 < 0.001 
Lowest SpO2, % 86.2 ± 0.3 76.4 ± 1.1 < 0.001 
Total time SpO2 < 90%, min 4.8 ± 1.2 31.0 ± 5.4 < 0.001 
Epworth Sleepiness Scale score 7.0 ± 0.3 6.7 ± 0.6 < 0.001 
Data are presented as mean ± standard deviation or number (percentage). 
AHI, apnea–hypopnea index; BMI, body mass index; ODI, oxygen 
desaturation index defined as number of 3% drops in oxygen saturation per 
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3.3.4 Prevalence of SDB and SAS 
There was a wide range of AHI scores between 0 to 81 events per hour. One 
hundred seventy-six participants (72.7%), 67 participants (27.7%) and 26 
participants (10.7%) had mild-to-severe, moderate-to-severe and severe SDB, 
respectively. Sixty-two out of 242 (25.6%) participants had an ESS score ≥10. 
The population estimates of the different SDB severities and SAS (SDB 
presented together with daytime sleepiness) are shown in Figure 7. The whole 
population estimate of moderate-to-severe SDB was 30.5%. Malays (33.8%) 
and Chinese (32.1%) had higher estimated moderate-to-severe SDB rates, 
while Indians (16.5%) and Others (12.0%) had lower rates (P =0.04). The 
whole population estimate of SAS was 18.1%.  Although not statistically 
different, the SAS prevalence rate was higher in Malays as compared to 
Chinese and Indians (22.9% vs 17.2% vs 11.7%). Only six out of 67 (9.0%) 
participants with moderate-to-severe SDB reported a prior physician diagnosis 
of sleep apnea.  
 
The corresponding estimated prevalence rates of SDB and SAS using AASM 
2007 criteria are shown in Supplementary Figure S1. As expected, prevalence 
rates were lower using the more stringent criteria of AHI4. The whole 
population estimates of moderate-to-severe SDB and SAS prevalence rates 
were 26.1% and 16.6% while the prevalence of moderate-to-severe SDB for 
































Figure 7. Weighted, estimated population prevalence rates for SDB using 
























































































Sleep apnea syndrome 
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3.3.5 Factors Associated with Moderate-to-severe SDB 
Table 15 shows the univariate regression of factors associated with moderate-
to-severe SDB and a multiple logistic regression model that identifies 
significant independent risk factors. Ethnicity, sex, age and obesity were 
associated with an increased risk of moderate-to-severe SDB in the univariate 
analysis. These factors remained significantly associated with moderate-to-
severe SDB even after adjustment in the multiple logistic regression models. 
In particular, ethnicity was identified as a factor independently associated with 
moderate-to-severe SDB after adjustment for age, sex and BMI, with Indians 
having lower odds of moderate-to-severe SDB as compared to Chinese (odds 















  CHAPTER 3  
 66 
Table 15. Odds ratio of demographic factors with moderate-to-severe SDB 
 
 Unadjusted OR  P-value Adjusted OR  P-value 
Ethnicity     
   Chinese 1  1  
   Malays  1.02 (0.87- 1.19) 0.84 0.91 (0.75 - 1.11) 0.35 
   Indians 0.86 (0.74 - 1.00) 0.045 0.82 (0.70 - 0.96) 0.02 
   Others 0.82 (0.65 – 1.03) 0.09 0.82 (0.69 - 0.98) 0.03 
Sex     
   Female 1  1  
   Male 1.20 (1.01 - 1.44) 0.044 1.21 (1.03 - 1.42) 0.03 
Age group     
   21-40 years 1  1  
   41-60 years 1.19 (0.99 – 1.44) 0.07 1.19 (1.00 – 1.41) 0.049 
   ≥ 61 years 1.25 (1.01 – 1.55) 0.04 1.31 (1.06 – 1.62) 0.01 
BMI category     
   BMI < 23  
sskg/m2 
1  1  
   BMI = 23- 
ss27.5 kg/m2          
1.05 (0.88 – 1.29) 0.53 0.99 (0.82 – 1.21) 0.95 
   BMI > 27.5 ff 
sskg/m2 
1.32 (1.05 – 1.66) 0.02 1.35 (1.05 – 1.75) 0.02 
Data are presented as odds ratio (95% confidence interval). 
Adjusted odds ratio from a logistic regression model for AHI ≥15 and each 
risk factor assessed individually, adjusted for ethnicity, sex, age and BMI, not 
including the variable being modeled. 
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3.3.6 Public Awareness of SDB 
Out of the 256 participants who agreed to participate in the current study, 
there were 217 completed questionnaires (response rate 84.8%) which 
assessed the awareness and knowledge of SDB. Only 78 (35.9%) could 
correctly define SDB. A total of 48 (22.1%) and 80 (36.9%) respondents 
correctly listed ≥1 risk factor or symptom for SDB, respectively. Among 84 
respondents with a STOP-BANG score ≥ 3, 24 (28.6%) correctly defined 
SDB, 16 (19.0%) correctly listed ≥1 risk factors and 29 (34.5%) correctly 
listed ≥1 symptoms. Among 61 participants who had moderate-to-severe SDB, 
only 11 (18.0%) correctly defined SDB, 6 (9.8%) correctly listed ≥1 risk 
factors and 11 (18.0%) correctly listed ≥1 symptoms. Significant predictors 
for incorrectly defining SDB included low education (OR 0.04, 95% 
confidence interval 0.007-0.18), ethnicity (Chinese baseline; Malay OR 0.44, 
95% confidence interval 0.20-0.93; Indian OR 0.31, 95% confidence interval 
0.14-0.73) and a diagnosis of moderate-to-severe SDB on the home-based 










  CHAPTER 3  
 68 
3.4 DISCUSSION 
3.4.1 Prevalence of SDB among Different Ethnic Groups 
To our knowledge, this is the first study to estimate SDB prevalence in the 
Singapore population and quantify differences in prevalence rates among the 
three Asian ethnic groups using home-based sleep studies and the latest 
AASM 2012 criteria. We found a high prevalence of moderate-to-severe SDB 
of 30.5% compared to previous studies. A 2001 study which looked at office-
based Chinese males aged 30-60 years found a moderate-to-severe SDB 
prevalence rate of 5.3%.(Ip et al., 2001) Another 2004 study conducted in 
Indian men aged 35-65 years coming to hospital for health screening reported 
a moderate-to-severe SDB prevalence rate of 8.4%.(Udwadia et al., 2004) The 
lower rates in these earlier studies could be accounted by two factors. Firstly, 
office workers and health screening volunteers may be healthier than a random 
sample from the general population. Secondly, SDB is common in the elderly, 
increasing significantly in those above 65 years.(Punjabi, 2008) However, 
both studies excluded subjects older than 65 years. 
 
The high prevalence seen in our study could also be accounted by technical 
factors. The increased sensitivity of nasal pressure sensors compared to 
thermistors and improvements in pulse oximeters would lead to detection of 
more hypopneas and hence higher AHIs.(Teichtahl, Cunnington, Cherry, & 
Wang, 2003; Zafar et al., 2005) Indeed, our prevalence rates are within the 
range of 9.8-49.7% reported in recent studies that used nasal pressure sensors 
instead of thermistors.(Chen et al., 2015; Heinzer et al., 2015b; S. Redline et 
al., 2014) We also used the more liberal AASM 2012 criteria to score 
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hypopneas that could have led to a higher SDB prevalence. However, even 
when we used the stricter 2007 AASM criteria, our estimated population 
prevalence was 26.1%, which is still higher than previously reported rates. 
 
We found no difference in ESS scores between subjects with AHI <15 and 
AHI ≥15. This is consistent with studies performed in population-based and 
sleep clinic settings that found no association between severity of SDB and 
ESS scores. (Cowan et al., 2014; Heinzer et al., 2015b) One explanation is that 
sleepiness is non-specific of SDB but is associated with other prevalent 
conditions such as insufficient sleep, insomnia and depression. 
 
We found lower odds of moderate-to-severe SDB among Indians compared 
with Chinese that remained significant after adjustment for age, sex, and BMI, 
suggesting that ethnicity is a risk factor for SDB. Previous studies have also 
reported ethnic inequalities in SDB prevalence.(Ancoli-Israel et al., 1995; 
Mihaere et al., 2009; Pranathiageswaran et al., 2013; Yamagishi et al., 2010; 
Young et al., 2002) Some investigators found that the difference in prevalence 
rates was explained by a difference in BMI distribution.(Mihaere et al., 2009; 
Yamagishi et al., 2010; Young et al., 2002) In contrast, others reported that 
ethnicity was an independent risk factor for SDB even after controlling for 
BMI.(Ancoli-Israel et al., 1995; Pranathiageswaran et al., 2013) Consistent 
with our findings, Chen et al found that Chinese had the highest odds of SDB 
compared to Whites after controlling for BMI when they examined for 
differences in SDB among Whites, Blacks, Hispanics and Chinese.(Chen et 
al., 2015) Previous clinic-based studies have also shown that Chinese have 
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more severe SDB compared to Whites when matched for BMI.(R. W. Lee et 
al., 2010; Li, Kushida, Powell, Riley, & Guilleminault, 2000) This 
predisposition to SDB could be accounted for by the fact that Chinese have 
more severe craniofacial restriction as compared to Whites.(R. W. Lee et al., 
2010; Liu, Lowe, Zeng, Fu, & Fleetham, 2000) However, SDB pathogenesis is 
complex and factors such as neuromuscular control of breathing and arousal 
threshold could also differ by ethnicity and warrants further study. 
Interestingly, we found that although Chinese had significantly lower BMI 
than Malays, both had similar SDB prevalence rates. This suggests that 
Chinese could also be at increased risk of SDB compared to Malays. 
However, we did not find that Malays had lower odds of SDB in our multiple 
logistic regression models, possibly due to our small sample size. 
 
3.4.2 Poor public knowledge of SDB 
Among participants with moderate-to-severe SDB, 91.0% were previously 
undiagnosed. Two recent studies conducted in the United States reported that 
83-95% of participants with moderate-to-severe SDB did not have a prior 
physician diagnosis of sleep apnea.(Chen et al., 2015; S. Redline et al., 2014) 
These data suggest that despite increasing SDB prevalence, undiagnosed sleep 
apnea remains a problem not only in the West but also in Asia. As shown by 
the follow-up survey, public awareness and knowledge of SDB is poor, 
despite having participated in the study. Respondents with low education, of 
Malay and Indian race and moderate-to-severe SDB had the least knowledge.  
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3.4.3 Limitations 
One of the main limitations of our study is small sample size (n=16) of the 
minority ethnic group ‘Others’. There could be a play of chance in the 
estimated prevalence of SDB and SAS in this heterogeneous ethnic group. 
Therefore, extrapolation of this finding to the general population of Singapore 
needs to be carried out with caution. We used type 3 monitor home-based 
sleep studies instead of in-laboratory polysomnography, which is the gold 
standard for SDB diagnosis. This is due to the limited accessibility of in-
laboratory polysomnography in Singapore, which has long waiting lists and is 
usually reserved for patients with clinical indications. Furthermore, full 
polysomnography that involve visiting the laboratory might be less well-
accepted and response rates are likely to decrease because study subjects in 
the general population are usually unwilling to travel to the hospital for an in-
laboratory sleep study due to the inconvenience. Portable monitors have a 
several drawbacks including the lack of electroencephalogram signal for 
determination of sleep times and arousals that may lead to inaccurate 
estimations of AHI. Nonetheless, comparison between a type 3 portable 
monitor device and polysomnography in a general population found that 
portable monitor AHIs had good concordance with polysomnography 
AHIs.(S. Vat et al., 2015) 
 
3.4.4 Conclusion 
In conclusion, we found that SDB is prevalent but mostly undiagnosed among 
Asians in Singapore, indicating a large public burden of untreated patients. 
The estimated population prevalence of moderate-to-severe SDB, defined as 
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AHI of ≥15, was 30.5%. Indians had lower odds of moderate-to-severe SDB 
compared to Chinese that remained after adjustment for age, sex, and BMI. 
Strategies are needed to optimize diagnosis and recognize ethnic differences in 
SDB prevalence.  
In addition, public awareness and knowledge of SDB is poor. Therefore, 
considerable educational effort is needed to raise public awareness, especially 
for community individuals who had low education backgrounds and are of 
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CHAPTER 4: PREDICTIVE POWERS OF STOP-BANG AND BERLIN 
QUESTIONNAIRES IN THE GENERAL POPULATION 
4.1 INTRODUCTION 
The STOP-BANG and BQ were developed as simple and quick screening 
tools used in the clinical settings to identify patients with SDB for further 
diagnosis and therapy.(Boynton, Vahabzadeh, Hammoud, Ruzicka, & 
Chervin, 2013; Chung et al., 2012; Chung et al., 2008a; Guralnick, Pant, 
Minhaj, Sweitzer, & Mokhlesi, 2012; Ong, Raudha, Fook-Chong, Lew, & 
Hsu, 2010; Vana, Silva, & Goldberg, 2013) 
 
In a recent meta-analysis looking at the performance of STOP-BANG 
questionnaire in different populations, the sensitivity and negative predictive 
value for moderate-to-severe SDB in the preoperative population were high at 
91% and 84%, respectively. The specificity and positive predictive value were 
low at 32% and 46%, respectively. In the sleep clinic population, the 
sensitivity and negative predictive value of the STOP-BANG questionnaire for 
moderate-to-severe SDB were also high at 94% and 75%, respectively. The 
specificity and positive predictive value were 34% and 72%.(Nagappa et al., 
2015) 
 
A high-risk classification on the BQ in the primary care setting was associated 
with a sensitivity of 86% and specificity of 77% for an AHI cut-off of >5 and 
a sensitivity of 54% and specificity of 97% for a AHI >15, 
respectively.(Netzer, Stoohs, Netzer, Clark, & Strohl, 1999) A study 
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conducted in 2012 compared the predictive probabilities of STOP-BANG and 
BQ for SDB in a cohort of Egyptian patients attending sleep clinic.(El-Sayed, 
2012) Both STOP-BANG and BQ had high sensitivities in detecting 
moderate-to-severe SDB (97.74% and 95.48%, respectively) and severe SDB 
(98.65% and 97.3%, respectively). However, both had low specificities for 
moderate-to-severe SDB (STOP-BANG 3.7%, BQ 7.41%) and severe SDB 
(STOP-BANG 5.36%, BQ 10.71%). Hence, these two questionnaires could 
successfully pick out patients at risk for SDB but without accurately ruling out 
those at low risk. 
 
Nevertheless, community individuals differ from preoperative and sleep clinic 
subjects. The general population has a lower prevalence of SDB and the 
majority of subjects with SDB in this cohort are asymptomatic.(Bixler et al., 
2005; Boynton et al., 2013; Chung et al., 2012; Kapur, Baldwin, Resnick, 
Gottlieb, & Nieto, 2005; A. Tan et al., 2016) To date, there are limited studies 
done and the performance of STOP-BANG and BQ in the general population 
remains unknown in view of differences in population characteristics.(Chung, 
Abdullah, & Liao, 2015) This study aimed to examine the diagnostic 
properties of STOP-BANG and BQ in predicting SDB in the local general 
population setting using both the latest 2012 and 2007 AASM scoring 
criteria.(Berry et al., 2012; Iber, S, AL, & SF) In addition, as Asians have 
similar prevalence rates of SDB compared to Whites despite lower BMIs 
(Chen et al., 2015; Ip et al., 2001; Kim et al., 2004), we examined if using 
lower BMI cutoffs of 27.5 and 30 would improve the STOP-BANG 
questionnaire’s performance in a multiethnic Asian population.  
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4.2 MATERIALS AND METHODS 
4.2.1 Study Subjects 
The study was conducted on the same pool of participants as Chapter 3 from 
the SH2012 cohort. A total of 256 participants underwent the home-based 
sleep test and completed the STOP-BANG and BQ. 
 
4.2.2 Anthropometry 
Anthropometric measurements such as weight, neck and waist circumferences 
were recorded. 
 
4.2.3 SDB Screening Questionnaires 
On the evening prior to the sleep test, all participants were handed the STOP-
BANG and BQ for self-administration to find out the questionnaires’ 
predictive powers. As Singapore is a multiethnic nation, we translated the 
STOP-BANG and BQ into Chinese, Malay, and Tamil versions in order to 
maximize the number of responses. The questionnaires were first translated 
into Chinese, Malay, and Tamil versions by a professional translation 
company. The translated versions were then back-translated into English by 
clinicians who were proficient in the respective languages. The clinicians 
decided on the final version of the translated questionnaires. Study subjects 
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4.2.4 Home-Based Sleep Test 
To test the predictive properties of the questionnaires against SDB diagnosis, 
sleep testing was performed with a type 3 portable monitor device. Data was 
scored using both the 2012 (scoring hypopneas with desaturation of ≥3%) and 
2007 (scoring hypopneas with desaturation of ≥4%) AASM scoring criteria 
between October 2014 and May 2015. Moderate-to-severe and severe SDB 
were defined as AHI ≥15 and 30 events per hour, respectively. 
 
4.2.5 Statistical Analysis 
General demographics, anthropometrics, sleep test and questionnaire data 
were summarized as means and standard deviations for continuous variables 
and percentages for categorical variables. Sensitivities, specificities, positive 
predictive value and negative predictive value, positive and negative 
likelihood ratios and area under the receiving operator curve were calculated 
for a STOP-BANG score ≥3 and high risk BQ classification for prediction of 
moderate-to-severe SDB and severe SDB. We then assessed the above 
diagnostic properties of STOP-BANG with two different Asian BMI cut-off 
points of 27.5 and 30 to look for any significant change in the questionnaire’s 
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4.3 RESULTS 
4.3.1 Baseline Characteristics of Participants 
The baseline and questionnaire characteristics of participants in the current 
study are summarized in Table 13. 
 
4.3.2 Prevalence of SDB  
The prevalence of moderate-to-severe SDB and severe SDB in the present 
cohort were 28.1% and 10.7%, respectively. 
 
4.3.3 Predictive Performance of STOP-BANG 
The majority of subjects completed the English version of the questionnaires 
(87.2%), while only 8.3% and 4.5% of subjects completed the Chinese and 
Malay versions, respectively. The Tamil version was not used at all. The 
STOP-BANG questionnaire characteristics of the participants are shown in 
Table 16. The mean score of the STOP-BANG was 2.1 ± 1.5 and 89 (36.8%) 
subjects were classified as high risk of SDB with a score of ≥3. Predictive 
parameters for STOP-BANG at AHI cutoffs of ≥15 and 30 are shown in Table 
17. Using a STOP-BANG score of ≥3 to detect moderate-to-severe SDB, the 
sensitivity was 66.2%, the specificity was 74.7%, the negative predictive value 
was 85% and the positive predictive value was 50.6%. Using a STOP-BANG 
score of ≥3 to detect severe SDB, the sensitivity was 69.2%, the specificity 
was 67.1%, the negative predictive value was 94.8% and the positive 
predictive value was 20.2%. As the most recent 2012 AASM guidelines has 
not been widely adopted till date, there are still a significant number of sleep 
laboratories which score sleep studies using the 2007 AASM guidelines. The 
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corresponding parameters for STOP-BANG using AHI4 scored according to 
the 2007 AASM criteria are shown in Supplemental Table S3. Using the more 
stringent AHI4 scoring criteria, the corresponding negative predictive values 
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Table 16. STOP-BANG questionnaire characteristics 
 
Questionnaire Subjects with 
positive response 
Do you Snore Loudly (loud enough to be heard through 
closed doors or your bed partner elbows you for snoring 
at night) 
50 (20.7) 
Do you often feel Tired, Fatigued, or Sleepy during the 
daytime (such as falling asleep during driving) 
96 (39.7) 
Has anyone Observed you Stop Breathing or 
Choking/Gasping during your sleep 
26 (10.7) 
Do you have or are being treated for High Blood 
Pressure? 
47 (19.4) 
BMI > 35 14 (5.8) 
Age > 50 116 (47.9) 
Neck circumference > 40 cm 38 (15.7) 
Gender male 122 (50.4) 
Subjects with score ≥ 3 89 (36.8) 
STOP-BANG score 2.1 ± 1.5 
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Table 17. Predictive parameters for STOP-BANG questionnaire using AASM 
2012 scoring criteria 
 
 AHI ≥15 AHI ≥30 
Sensitivity, % 66.2 (53.7-77.2) 69.2 (48.2-85.7) 
Specificity, % 74.7 (67.6-81.0) 67.1 (60.4-73.4) 
PPV, % 50.6 (39.8-61.3) 20.2 (12.4-30.1) 
NPV, % 85.0 (78.3-90.2) 94.8 (90.0-97.7) 
LR+ 2.61 2.11 
LR- 0.45 0.46 
Area under ROC curve 0.766 (0.702-0.830) 0.742 (0.628-0.856) 
Data are presented as average (95% confidence interval). 
AHI, apnea–hypopnea index; NPV, negative predictive value; PPV, positive 
predictive value; LR+, positive likelihood ratio; LR-, negative likelihood ratio; 

















  CHAPTER 4  
 81 
4.3.4 Using STOP-BANG Questionnaire at Lower BMI Cutoffs 
Predictive parameters using STOP-BANG questionnaire with lower BMI 
cutoffs of 27.5 and 30 to predict moderate-to-severe and severe SDB are 
shown in Table 18. As expected, lowering the cutoffs increased sensitivity of 
the questionnaire but there was a corresponding decrease in specificity. Using 
a BMI cutoff of 30 instead of 35, the sensitivity of a STOP-BANG score ≥3 to 
detect an AHI ≥15 increased from 66.2% to 69.1% but there was also a 
decrease in specificity from 74.7% to 73.0%. Using a BMI cutoff of 27.5 
instead of 35, the sensitivity of a STOP-BANG score to detect an AHI ≥15 
increased from 66.2% to 70.6% but again there was a decrease in specificity 
from 74.7% to 70.1%. Area under the receiving operator curve for all BMI 
cutoffs clustered around 0.742 to 0.774. The predictive parameters for the 
STOP-BANG questionnaire using lower BMI cutoffs to predict AHI4 defined 
moderate-to-severe and severe SDB are shown in Supplemental Table S4. 
Again, any increase in sensitivity with the use of a lower BMI cutoff was 
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Table 18. Predictive parameters of STOP-BANG questionnaire for moderate-
to-severe and severe SDB at different BMI cutoffs 
 
 BMI ≥35 BMI ≥30 BMI ≥27.5 
AHI ≥15    
  Sensitivity, % 66.2 (53.7-77.2) 69.1 (56.7-79.8) 70.6 (58.3-81.0) 
  Specificity, % 74.7 (67.6-81.0) 73.0 (65.7-79.4) 70.1 (62.7-76.8) 
  PPV, % 50.6 (39.8-61.3) 50.0 (39.5-60.5) 48.0 (37.9-58.2) 
  NPV, % 85.0 (78.3-90.2) 85.8 (79.1-91.0) 86.0 (79.1-91.2) 
  Area under ROC 







AHI ≥30    
  Sensitivity, % 69.2 (48.2-85.7) 73.1 (52.2-88.4) 73.1 (52.2-88.4) 
  Specificity, % 67.1 (60.4-73.4) 65.3 (58.5-71.6) 62.5 (55.7-69.0) 
  PPV, % 20.2 (12.4-30.1) 20.2 (12.6-29.8) 19.0 (11.8-28.1) 
  NPV, % 94.8 (90.0-97.7) 95.3 (90.5-98.1) 95.1 (90.1-98.0) 
  Area under ROC   







Data are presented as average (95% confidence interval). 
AHI, apnea–hypopnea index; BMI, body mass index; NPV, negative 
predictive value; PPV, positive predictive value; ROC, receiver operating 
characteristics. 
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4.3.5 Predictive Performance of Berlin Questionnaire 
Table 19 shows the breakdown of positive responses in the individual 
categories of the BQ. Overall, 79 (32.6%) participants were classified as high-
risk by the questionnaire. A total of 110 (45.5%) participants scored positively 
in category one, which evaluates snoring. This is due to the fact that we 
oversampled snorers and 137 (56.6%) participants were already identified as 
snorers based on the Pittsburg Sleep Quality Index. Sixty (24.8%) participants 
scored positively in category two, which determines the presence of excessive 
daytime sleepiness while 79 (32.6%) participants scored positively in category 
three, which assesses the presence of hypertension or obesity. Table 20 depicts 
the diagnostic properties of the BQ to predict moderate-to-severe SDB and 
severe SDB using AASM 2012 scoring criteria. A high-risk classification on 
the BQ predicted moderate-to-severe SDB with a sensitivity of 58.8%, a 
specificity of 77.6%, a negative predictive value of 82.9% and a positive 
predictive value of 50.6%. The area under the receiving operator curve was 
0.682. When used to predict severe SDB, the sensitivity of a high risk 
classification rose to 76.9%, specificity remained moderately high at 72.7% 
and the corresponding negative predictive value increased to 96.3% while 
positive predictive value dropped to 25.3%. The area under the receiving 
operator curve also improved to 0.748. Supplemental Table S5 shows similar 
predictive parameters as Table 20, but using AASM 2007 scoring criteria 
instead. The screening properties of the BQ improved further when using the 
AASM 2007 scoring criteria.  
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Table 19. Breakdown of positive responses to the Berlin Questionnaire 
 
Berlin Questionnaire  Positive responses 
High-risk 79 (32.6) 
Category 1 (Snoring) 110 (45.5) 
Do you snore?  
     Yes 151 (62.4) 
Your snoring is   
     Louder than talking/very loud 25 (10.3) 
How often do your snore  
     Almost every day/3-4 times a week 94 (38.9) 
Does your snoring bother other people  
     Yes 70 (28.9) 
Has anyone noticed that you quit breathing during 
your sleep 
 
     Almost every day/3-4 times a week 7 (2.9) 
Category 2 (Daytime sleepiness) 60 (24.8) 
Are you tired after sleeping  
     Almost every day/3-4 times a week 70.3 (30.2) 
Are u tired during wake time  
    Almost every day/3-4 times a week 70.3 (30.2) 
Have you ever nodded off or fallen asleep while 
driving 
 
     Yes 25 (10.3) 
If yes, how often does it occur  
     Every day/3-4 times a week 3 (1.2) 
Category 3 ( hypertension or obesity) 79 (32.6) 
Do you have high blood pressure  
     Yes       47 (19.4) 
BMI > 30 kg/m2 40 (16.5) 
Data are presented as number (percentage). 
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Table 20. Predictive parameters for Berlin questionnaire using AASM 2012 
scoring criteria 
 
 AHI ≥ 15 AHI ≥ 30 
Sensitivity, % 58.8 (46.2-70.6) 76.9 (56.3-91.0) 
Specificity, % 77.6 (70.7-83.5) 72.7 (66.2-78.5) 
PPV, % 50.6 (39.1-62.1) 25.3 (16.2-36.4) 
NPV, % 82.9 (76.1-88.3) 96.3 (92.2-98.6) 
LR+ 2.62 2.82 
LR- 0.53 0.32 
Area under ROC 
curve 
0.682 (0.615-0.749) 0.748 (0.660-0.836) 
Data are presented as average (95% confidence interval). 
AHI, apnea–hypopnea index; NPV, negative predictive value; PPV, positive 
predictive value; LR+, positive likelihood ratio; LR-, negative likelihood ratio; 
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4.4 DISCUSSION 
To our knowledge, this is the first study to examine the validity of the STOP-
BANG and BQ to detect SDB in the general population using the latest 
AASM 2012 scoring criteria.  
 
4.4.1 Validity of STOP-BANG in the General Population 
We found a moderate sensitivity of 66.2% and 69.2% for a STOP-BANG 
score of ≥3 to detect moderate-to-severe and severe SDB, respectively. The 
corresponding negative predictive values were high at 85% and 94.8%, 
respectively. We found a lower sensitivity but higher specificity of the 
questionnaire when used in the general population as compared to its usage in 
the sleep clinic and preoperative populations.(Nagappa et al., 2015) The 
STOP-BANG questionnaire is a summation of the common symptoms and 
risk factors associated with SDB, such as advanced age and obesity. Subjects 
who present to the sleep clinic are more likely to report symptoms and have a 
more severe spectrum of disease, which would make detection of sleep apnea 
via the questionnaire easier hence, increasing its sensitivity. Similarly, 
subjects in the preoperative population are likely to be more symptomatic and 
have more comorbidities such as advanced age and increased rates of obesity 
as compared to a random sample of the general population. Again, this would 
increase the sensitivity of the questionnaire in the preoperative setting. A 
recent population based study found that the majority of subjects with 
moderate-to-severe SDB in the general population were mostly asymptomatic 
and not sleepy (Arnardottir et al., 2016). This suggests that subjects in the 
general population as compared to clinical populations like sleep clinic 
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patients and preoperative subjects are less likely to report that they snore, feel 
tired or choke during sleep, all of which are components of the STOP-BANG 
questionnaire and this would explain its decreased sensitivity. Conversely, 
subjects in the community who do report that they snore loudly or are sleepy 
are more likely to have severe symptoms, which would explain the increased 
specificity of the questionnaire in the general population setting. Our findings 
are consistent with Silva et al. who evaluated the STOP-BANG questionnaire 
in 4770 participants in the Sleep Heart Health Study. (Silva, Vana, Goodwin, 
Sherrill, & Quan, 2011) They found a reduced sensitivity and increased 
specificity of the questionnaire when used in the community setting as 
compared to the preoperative population. They reported that the sensitivity of 
a STOP-BANG score of ≥3 was 87.0% to detect moderate-to-severe SDB and 
70.4% to detect severe SDB. The corresponding specificities were 43.3% and 
59.5%, respectively.  
 
Despite the moderate sensitivity, we believe that the STOP-BANG 
questionnaire can be used as a screening tool in the general population in view 
of its high negative predictive value. Negative predictive value is 
predominantly determined by sensitivity of the test and the prevalence of the 
disease in the population studied. The prevalence of moderate-to-severe SDB 
(28.1%) in our general population sample is considerably lower than what has 
been reported in the sleep clinic (64%) and preoperative population (39.2%) 
settings (Nagappa et al., 2015), which contributed to the high negative 
predictive values that we found. Clinicians and health care personnel involved 
in health screening programs and primary care that see patients for unrelated 
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problems can use STOP-BANG questionnaire to exclude subjects with very 
little chance of moderate-to-severe SDB and prioritize subjects for further 
testing. 
 
4.4.2 Performance of STOP-BANG at Lower BMI Cutoffs 
We found that using lower cutoffs of BMI did not significantly improve the 
performance of the STOP-BANG questionnaire in a multiethnic Asian 
population setting. As expected, lower cutoffs improved the sensitivity of the 
questionnaire but the specificity dropped correspondingly. Ong et al. found 
that a BMI cutoff of 30 led to an increase in sensitivity of the STOP-BANG 
questionnaire from 91.3% to 93.8% while specificity was unchanged at 40.4% 
(Ong et al., 2010). Hence, the authors concluded that using a cutoff of 30 
would simplify the application of the tool without affecting performance in a 
multiethnic Asian population. These findings could be explained by 
differences in patient populations. Ong et al examined the utility of STOP-
BANG in the sleep clinic setting where the reported prevalence of moderate-
to-severe SDB was higher (50.9%) than ours (28.1%). In addition, their study 
had more obese subjects, as 28.8% of their study sample had a BMI >30 while 
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4.4.3 Validity of Berlin Questionnaire in the General Population 
We found that the BQ may have utility as a screening tool in the general 
population setting in view of the good sensitivity (76.9%) and high negative 
predictive value (96.3%) in ruling out severe SDB. When used to predict 
moderate-to-severe SDB, we found that the sensitivity was moderate at 58.8% 
with a specificity of 77.6% and a moderately high negative predictive value of 
82.9% and a low positive predictive value of 50.6%. The screening properties 
of the BQ improved significantly when used to predict severe SDB, with 
sensitivity, specificity, negative predictive value and positive predictive value 
of 76.9%, 72.7%, 96.3% and 25.3% respectively. As the AASM 2012 criteria 
have not been widely adopted to date, many sleep laboratories worldwide still 
use the AASM 2007 criteria. We found that the screening properties of the 
questionnaire to rule out severe SDB improved further when using AASM 
2007 criteria, with a sensitivity of 80% and a negative predictive value of 
97.5%. However, it is important to take note that the positive predictive values 
are low, ranging from 20.3% to 50.6%, depending on the cut-off of AHI and 
AASM criteria used. Hence, the questionnaire can only be used primarily as a 
screening tool to rule out SDB. Subjects who are classified as high-risk will 
require further diagnostic testing. 
 
Our findings are similar to the study by Kang et al, where they found that the 
sensitivity and specificity of the BQ to predict moderate-to-severe SDB was 
89.0% and 63.0%, respectively. No negative predictive value or positive 
predictive value were reported for that study but 26 (25.7%) out of 101 of 
subjects who underwent sleep studies had an AHI ≥15, which is close to the 
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prevalence of 28.1% that we found.(Kang et al., 2013) The authors concluded 
that the questionnaire maybe a useful tool to prioritize subjects at high risk of 
SDB in the general population. In contrast, Hrubos-Strom et al found that 
screening properties of the BQ in the general population was suboptimal, with 
a sensitivity of 37.2% and a specificity of 84.0% to predict moderate-to-severe 
SDB.(Hrubos-Strom et al., 2011) One of the possible reasons could be that the 
prevalence of SDB in this Norwegian study was very low, with an estimated 
prevalence of moderate-to-severe SDB of only 8.0%. Populations with a 
higher prevalence of SDB are likely to have more subjects who are 
symptomatic or have associated comorbidities, giving rise to higher 
sensitivities. Apart from differences in the types of sleep studies performed 
and the scoring criteria used, we also postulate that the variation in the 
diagnostic properties of the BQ in these population-based studies performed to 
date could be due to the fact that the questionnaire is largely composed of 
subjective questions. A person’s assessment of his/her snoring severity and 
daytime fatigue is personal and prone to bias.  
 
4.4.4 Consistency between Existing Studies on STOP-BANG and Berlin 
Questionnaires 
A recent meta-analysis looking at the STOP-BANG questionnaire in various 
populations found that the diagnostic properties of STOP-BANG were 
generally consistent with high sensitivities and low specificities,(Nagappa et 
al., 2015) which is in contrast to the large variation reported in different 
studies looking at the predictive accuracy of the BQ.(Ahmadi, Chung, Gibbs, 
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& Shapiro, 2008; Chung et al., 2008b; Gus et al., 2008; S. K. Sharma et al., 
2006)  
 
4.4.5 Utility of Questionnaires in Ruling out Severe SDB 
The predictive powers of both questionnaires improved with disease severity, 
hence making them ideal for use to rule out severe SDB in the general 
population setting. In fact, recent population-based studies have found that 
only the highest quartile of AHI or severe SDB was associated with 
comorbidities such as hypertension, diabetes and depression. Similarly, 
another population-based study performed in Iceland found that approximately 
20% of subjects had moderate-to-severe SDB and were largely 
asymptomatic.(Arnardottir et al., 2016) These studies suggest that the cut-offs 
for treatment of SDB may need to be adjusted further upwards from the 
current AHI cut-off of 15.(Arnardottir et al., 2016; Bixler et al., 2016; Heinzer 
et al., 2015b) In that aspect, we found that the negative predictive value for a 
STOP-BANG score ≥3 to detect severe SDB (AHI ≥30) in the general 
population was 94.8%, higher than what has been reported in the sleep clinic 
setting (90%) and comparable to values reported in the preoperative 
population (97%) (Nagappa et al., 2015). 
 
4.4.6 Limitations 
One of the main limitations in our study is that we used portable sleep studies 
instead of in-laboratory polysomnography, which could lead to inaccurate 
estimations of AHI as total sleep time could not be determined and some 
hypopneas may not be identified due to the lack of electroencephalogram. An 
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erroneousness diagnosis of SDB would then affect the predictive parameters 
of the screening questionnaire. Another limitation was that this study was 
conducted in a multiethnic Asian nation and it remains unknown if our results 
could be extrapolated to Western populations. However, there has been no 
evidence to date that risk factors and clinical symptoms for SDB in Asian 
populations differ markedly from Western populations (Ip et al., 2001; Kim et 
al., 2004; Udwadia et al., 2004). In addition, the STOP-BANG questionnaire 
has been previously validated in Asian populations in a variety of settings with 
reported predictive parameters similar to studies performed in the West (Ha, 
Lee, Abdullah, & van Hasselt, 2014; Luo, Huang, Zhong, Xiao, & Zhou, 
2014; Ong et al., 2010; Yu, Mei, & Cui, 2012). Lastly, slightly more than half 
of our study sample (56.6%) consisted of snorers as we oversampled snorers. 
This could have led to spectrum bias and artificially inflated the sensitivities 
that we reported. High negative predictive values of a test are usually driven 
by high sensitivity of the test itself and a low prevalence of a disease. 
However, even with a moderately high prevalence of severe SDB (10.7%) in 
our study sample, we found that the negative predictive value of a low-risk 
BQ classification remained very high at 96.3%. We believe that when used in 
other general population settings where the sensitivity of the test may be 
reduced due to a lower proportion of snorers, the negative predictive value 
would still remain high, especially if the prevalence of severe SDB is lower 
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4.4.7 Conclusion 
In conclusion, we found that the STOP-BANG questionnaire had moderate 
sensitivity and high negative predictive value to predict moderate-to-severe 
SDB and severe SDB in the community setting. Hence, it can be used as a 
screening tool to prioritize subjects for further testing. The cutoff of BMI >35 
can be used in Asians as lower BMI cutoffs of 30 and 27.5 did not improve 
questionnaire performance significantly. Similarly, the BQ may also be used 
as a screening tool in the general population setting in view of its good 
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CHAPTER 5: VALIDATION AND COMPARISON OF THE NOSAS 
SCORE 
5.1 INTRODUCTION 
NoSAS is a novel screening tool created using modern recording technology 
and recent respiratory scoring criteria; hence it is believed to be of greater 
relevance to the current clinical practices. It is a shorter and more objective 
questionnaire than STOP-BANG and BQ as it assesses the least parameters 
(five questions), of which only one has a subjective response (snoring). 
 
Using a definition of SDB as AHI >20, the authors of the NoSAS score found 
that it had high negative predictive values of 90% and 98% in the HypnoLaus 
and EPISONO cohorts, respectively.(Marti-Soler et al., 2016b) Moreover, it 
outperformed the STOP-BANG and BQ in terms of diagnostic accuracy, as 
evidenced by higher area under the curve values.   
 
As the NoSAS score was only validated and compared against existing 
screening tools in a limited number of Western countries, its usefulness in the 
Asian context is unknown. The objective of this study was to validate the 
NoSAS score for screening of SDB in a multiethnic Asian population. 
Furthermore, its performance was compared against the widely used STOP-
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5.2 MATERIALS AND METHODS 
5.2.1 Study Subjects 
The study was conducted on the same pool of participants as Chapter 3 from 
the SH2012 cohort. A total of 256 participants underwent the home-based 
sleep test and completed the STOP-BANG and BQ. 
 
5.2.2 Anthropometry 
The requirements for anthropometric measurements such as BMI and neck 
circumference were measured and recorded by the sleep technician 
immediately after completion of the questionnaires. 
 
5.2.3 NoSAS Score 
On the evening prior to the sleep test, all participants completed the STOP-
BANG and BQ. Translated versions of the STOP-BANG and BQ in Chinese, 
Malay and Tamil were available and participants were given the 
questionnaires in their preferred language The NoSAS score was subsequently 
calculated based on available anthropometric and demographic data collected. 
The presence of snoring was determined by a positive response to the first 
question of the BQ.  
 
5.2.4 Home-Based Sleep Test 
The sleep testing was performed with a type 3 portable monitor device and 
data was scored using the latest AASM 2012 criteria (scoring hypopneas as at 
least a 30% reduction in airflow for at least 10s with desaturation of ≥ 3%) 
between October 2014 and May 2015 for comparison with the results of the 
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NoSAS score. Moderate-to-severe SDB was defined as an AHI ≥15 events/h 
and severe SDB was defined as an AHI ≥30 events/h. 
 
5.2.5 Statistical Analysis 
We summarized demographic, sleep study, and screening questionnaire data 
as means and standard deviations for continuous variables and percentages for 
categorical variables. The sensitivities, specificities, positive predictive value, 
negative predictive value, and area under the curve values were calculated for 
a NoSAS score ≥8, STOP-Bang score ≥3, and high-risk Berlin questionnaire 
classification to predict SDB at different AHI cutoffs of ≥15, 20, 25, and 30, 
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5.3 RESULTS 
5.3.1 Baseline Characteristics of Participants 
The baseline and questionnaire characteristics of participants in the current 
study are summarized in Table 13. 
 
5.3.2 Prevalence of SDB  
The prevalence of SDB at different AHI cutoffs of ≥15, 20, 25, and 30, were 
28.1%, 20.2%, 14.5% and 10.7%, respectively. 
 
5.3.3 Predictive Performance of NoSAS Score 
Table 21 shows the responses of the individual questionnaires. The number of 
high-risk subjects classified by the NoSAS score, STOP-BANG and BQ were 
76 (31.4%), 89 (36.8%), and 79 (32.6%), respectively. One hundred fifty-one 
subjects (62.4%) reported presence of snoring on the BQ while only 50 
subjects (20.7%) reported snoring loudly on the STOP-BANG questionnaire. 
 
Table 22 shows the diagnostic properties of the NoSAS score, STOP-BANG 
and BQ to predict SDB scored according to the AASM 2012 scoring criteria at 
various AHI cutoffs of ≥15, ≥20, ≥25, and ≥30 events/h. Using an AHI cutoff 
of ≥20 events/h, the sensitivity, specificity, positive predictive value, and 
negative predictive value of a high risk NoSAS score to predict SDB was 
69.4%, 78.2%, 44.7%, and 91.0%, respectively. The diagnostic properties of 
STOP-Bang and BQ to predict SDB at an AHI cutoff of ≥20 events/h were 
similar, with area under the curve values clustered around 0.692–0.738. Using 
an AHI cutoff of ≥30 events/h, the sensitivity and specificity of the NoSAS 
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score remained similar at 69.2% and 73.1%, respectively. However, due to the 
reduced prevalence of severe SDB at 10.7%, there was an increase in negative 
predictive value from 91.0% to 95.2% and a drop in positive predictive value 
from 44.7% to 23.7%. Again, the diagnostic properties of STOP-BANG and 
BQ at an AHI cutoff of ≥30 events/h did not differ significantly from the 
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Table 21. Responses of the NoSAS, STOP-BANG and Berlin questionnaires 
 
Questionnaire Subjects with positive response 
NoSAS score  
High risk 76 (31.4) 
Neck circumference >40 cm 38 (15.7) 
BMI 25 to <30 kg/m2 98 (40.5) 
BMI ≥30 kg/m2 40 (16.5) 
Snoring 151 (62.4) 
Age > 55 years 71 (29.3) 
Male 122 (50.4) 
STOP-Bang  
High risk 89 (36.8) 
Do you SNORE loudly? 50 (20.7) 
Do you often feel TIRED? 96 (39.7) 
Has anyone OBSERVED you 
stop breathing? 
26 (10.7) 
Do you have high blood 
PRESSURE? 
47 (19.4) 
BMI >35 kg/m2 14 (5.8) 
Age >50 years 116 (47.9) 
Neck circumference >40 cm 38 (15.7) 
Male 122 (50.4) 
Berlin questionnaire  
High risk 79 (32.6) 
Category 1 (snoring) 110 (45.5) 
Category 2 (daytime sleepiness) 60 (24.8) 
Category 3 (hypertension or BMI 
>30 kg/m2) 
79 (32.6) 
Data are presented as number (percentage) 
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Table 22. Diagnostic properties of NoSAS, STOP-BANG and Berlin 
questionnaires 
Data are presented as number (percentage).  
AHI, apnea–hypopnea index; PPV, positive predictive value; NPV, negative 




 NoSAS STOP-BANG BQ 
Proportion of high-risk score 76 (31.4) 89 (36.8) 79 (32.6) 
AHI ≥15 (events/h)    
Prevalence of SDB, % 28.1   
   Sensitivity, % 60.3 66.2 58.8 
   Specificity, % 79.9 74.7 77.6 
   PPV, % 53.9 50.6 50.6 
   NPV, % 83.7 85.0 82.8 
   AUC 0.701 0.704 0.682 
AHI ≥20 (events/h)    
Prevalence of SDB, % 20.2   
   Sensitivity, % 69.4 67.3 65.3 
   Specificity, % 78.2 71.0 75.6 
   PPV, % 44.7 37.1 40.5 
   NPV, % 91.0 89.5 89.6 
   AUC 0.738 0.692 0.705 
AHI ≥25 (events/h)    
Prevalence of SDB, %        14.5 
   Sensitivity, % 71.4 71.4 71.4 
   Specificity, % 75.4 69.1 73.9 
   PPV, % 32.9 28.1 31.6 
   NPV, % 94.0 93.5 93.9 
   AUC 0.734 0.703 0.727 
AHI ≥30 (events/h)    
Prevalence of SDB, %        10.7 
  Sensitivity, % 69.2 69.2 76.9 
  Specificity, % 73.1 67.1 72.7 
  PPV, % 23.7 20.2 25.3 
  NPV, % 95.2 94.8 96.3 
  AUC 0.712 0.682 0.748 




5.4.1 Validity of the NoSAS Score in the General Population 
To our knowledge, this is the first study to validate the NoSAS score in a 
multiethnic Asian population-based cohort using the latest AASM2012 
scoring criteria. Using a similar AHI cutoff of ≥20 events/h, we found that the 
sensitivity of NoSAS score was lower (69.4%) than reported in the 
HypnoLaus (79.0%) and EPISONO (85.0%) cohorts. However, the specificity 
(78.2%) was similar to both cohorts (69.0 and 77.0%, respectively). It is 
notable that despite the reduced sensitivity of the NoSAS score, the negative 
predictive value for our Asian cohort remained high at 91.0% and was 
comparable to the HyponaLaus (90.0%) and EPISONO (98.0%) cohorts.  
 
Apart from differences in sampling methodology, type of sleep studies 
employed and scoring criteria used, we believe that the reduced sensitivity of 
the NoSAS score in our cohort could be due to the fact that our sample was 
predominantly made up of Chinese. SDB subjects who fail to be identified as 
high-risk by the NoSAS score tend to have low BMI and neck circumference. 
On the NoSAS score, both BMI (three or five points) and neck circumference 
(four points) contribute considerably to a positive NoSAS score (at least eight 
points). It was reported previously that Chinese have high rates of SDB 
despite relatively low BMIs. The pathogenesis of SDB in Chinese could be 
related to other factors such as craniofacial restriction, neuromuscular control 
of upper airway or arousal threshold rather than obesity.(R. W. Lee et al., 
2010; Li et al., 2000)  
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5.4.2 Comparison of the NoSAS Score  
A comparison between the NoSAS score and the STOP-BANG and BQ 
revealed that all three questionnaires performed similarly when using AHI 
cutoffs of ≥20 and 30. The area under the curves clustered around 0.692 – 
0.738 and 0.682 - 0.748 for AHI ≥20 and ≥30, respectively. In particular, we 
found that the questionnaires had equally high negative predictive values in 
ruling out severe SDB (AHI ≥ 30) (94.8% -96.3%). A recent population-based 
study performed in Iceland found that moderate-to-severe SDB was highly 
prevalent but the majority was asymptomatic, suggesting that the threshold for 
clinically significant SDB should be pushed up further. (Arnardottir et al., 
2016) Hence, excluding severe SDB may be more relevant in the general 
population setting. 
 
Conversely, the positive predictive values for severe SDB were 
correspondingly low (20.2% - 25.3%). Hence, it is important to note that these 
questionnaires should only be used primarily as screening tools to rule out 
low-risk subjects for severe SDB. Subjects who are identified as high risk will 
need to undergo further investigations. We also compared the questionnaires 
at other AHI cutoffs of ≥15 and 25 events/h and were unable to detect any 
differences in performance. It is possible that our failure to find any statistical 
difference could be due to our small sample size. However, no single 
questionnaire appeared to be consistently superior at various AHI cutoffs.  
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As all three questionnaires appear to have similar performance in our cohort, 
the choice of questionnaire by the primary care physician may boil down to 
ease of use. The BQ is the most complex and may not be time efficient in busy 
clinical settings. The scoring of STOP-BANG is simple as one point is 
allocated to each positive response. Although the NoSAS score is more 
complicated as it assigns differential scoring to each variable, it limits the 
number of subjective variables to only snoring and has the fewest number of 
variables out of the three questionnaires. In addition, a free smartphone app 
has been made available by the developers of the NoSAS score to encourage 
primary care physicians to use the score.  
 
5.4.3 Limitations 
Similar to the previous study on STOP-BANG and BQ, we used portable 
monitoring devices instead of in-laboratory polysomnography which lack 
electroencephalography signals for determination of sleep times and 
hypopneas. This could lead to inaccurate estimations of AHI and affect the 
predictive parameters of the questionnaires. In addition, the sensitivity values 
in this study might have been inflated due to the oversampling of snorers. The 
negative predictive value of a diagnostic test is largely determined by the 
prevalence of the disease and the sensitivity of the test. However, even with a 
relatively high prevalence of severe SDB of 10.7%, the negative predictive 
values of the three questionnaires remained high at 94.8–96.3%. We believe 
that even if the true sensitivities of the questionnaire scores were lower, the 
negative predictive values of these questionnaires is likely to remain high, 
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especially when used in other populations where the prevalence of severe SDB 
may be lower than what we have reported. 
 
5.4.4 Conclusion 
In conclusion, we found that the NoSAS score performed similarly to the 
STOP-BANG and BQ in our multiethnic Asian cohort. All three 
questionnaires had high negative predictive values in ruling out severe SDB 
and have utility as screening tools. Ultimately, the choice of questionnaire to 
be used might then depend on its simplicity and objectivity. Future studies will 
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CHAPTER 6: PREDICTION OF EXERCISE FITNESS IN CARDIAC 
REHABILITATION PATIENTS BY SCREENING QUESTIONNAIRES  
6.1 INTRODUCTION 
To overcome the global shortage of sleep laboratories, screening 
questionnaires including the STOP-BANG, BQ and ESS have been 
increasingly used in clinical settings including cardiac rehabilitation to 
preliminarily stratify patients at risk for SDB.  
 
To date, the relative roles of the widely used SDB screening questionnaires 
(STOP-BANG, BQ and ESS) in predicting exercise fitness remain unknown. 
In this study, we sought to compare the usefulness of the three questionnaires 
in predicting exercise fitness, which was assessed by a simple 6MWT in a 
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6.2 MATERIALS AND METHODS 
6.2.1 Study Design 
This prospective study was performed in patients enrolled for late-phase 
cardiac rehabilitation in the Singapore Heart Foundation Heart Wellness 
Center. The local Institution Review Board approval (Parkway Independent 
Ethics Committee 2013/027) was obtained on 26 November 2013.  Patients 
who were unable to or refused to give informed consent, undergoing treatment 
for their known SDB, and those who had clinically significant arrhythmia, 
peripheral artery disease or receiving alpha-channel blockers were excluded 
from the study. Informed consent was obtained from each participant.   
 
6.2.2 Data Collection 
Demographics were collected from the recruited patients and these include 
age, gender, ethnicity, height, weight, BMI, body fat (%), visceral fat (%), 
neck and weight circumferences. Clinical data was also collected and 
information on the indication for cardiac rehabilitation (primary or secondary), 
cardiovascular risk factors (hypertension, diabetes mellitus, dyslipidemia, 
smoking status, family history of coronary artery disease), medical history of 
cardiovascular disease and other comorbidities were available. The subject 
pool consists of patients enrolled in the cardiac rehabilitation for both primary 
and secondary prevention. The primary prevention group consists of 
individuals who were not diagnosed with cardiovascular diseases but had high 
risk profiles. In contrast, patients who underwent treatment for cardiovascular 
diseases were enrolled under the secondary prevention group as they attended 
the cardiac rehabilitation to prevent recurrent disease. 
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6.2.3 SDB Screening Questionnaires 
All participants completed the STOP-BANG, BQ and ESS to investigate the 
questionnaires’ performances in predicting 6MWT performance. In this 
analysis, high risk of SDB was defined by positive results for STOP-BANG, 
BQ or the presence of excessive daytime sleepiness based on ESS.  
 
6.2.4 Assessment of Exercise Capacity 
The functional exercise capacities of participants were assessed by the 6MWT. 
The total distance walked by the participants within six minutes was recorded.  
 
6.2.5 Statistical Analysis 
Descriptive statistics such as means and standard deviations were used to 
describe the characteristics of the overall, primary and secondary prevention 
groups. In bivariate analyses, Student’s t tests and Chi-square tests were used 
to examine differences between primary and secondary prevention groups in 
continuous and discrete variables respectively. Multivariate linear regression 
models were used to assess the association of sleep questionnaire outcomes 
with distance travelled in the 6MWT. These models, with 6MWT as the 
outcome variable, were adjusted for variables chosen a priori. Significance 
level was set at P ≤0.05 for hypothesis driven tests, such as the likelihood ratio 
tests and Wald tests, in this study. All statistical analyses were performed 








6.3.1 Baseline Characteristics of Participants  
Among the 341 patients attending cardiac rehabilitation, 332 of them agreed to 
participate in this study and provided written informed consent. After 
excluding 10 patients who did not complete the 6MWT and 18 patients with 
missing or invalid data, 304 successfully completed all three screening 
questionnaires and the 6MWT. Among these 304 patients, 93 (30.6%) 
attended cardiac rehabilitation for primary prevention and 211 (69.4%) 
attended for secondary prevention.  
 
6.3.2 Prevalence of SDB  
The prevalence of SDB according to the results of the STOP-BANG, BQ and 
ESS was given in Figure 8. The prevalence was highest based on STOP-
BANG (52.0%) and lowest based on ESS (21.7%). A similar pattern was 
observed when the cohort was divided into primary and secondary prevention 
groups. 




Figure 8. Risk characteristics of patients defined by the three questionnaires  
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6.3.3 Association between the Questionnaires and 6MWT 
The average distance walked by the 304 study patients was 520.1 ± 88.3 
meters. Based on BQ, the distance walked was shorter in patients defined as 
high-risk versus low-risk for SDB (Figure 9). The patients defined as high-risk 
for SDB by BQ walked 21.3 ±10.7 meters (p=0.046) less than those defined as 
low-risk after adjusting for age, gender, ethnicity, height, BMI, body and 
visceral fat %, neck and waist circumference, existing cardiovascular risk 
factors, and past medical history. Based on STOP-BANG and ESS, the 
distance walked was similar between the patients defined as high-risk versus 
low-risk for SDB.  
 
We further analyzed the results by dividing the overall cohort into primary and 
secondary prevention groups. Consistent with the results in the overall cohort, 
patients in the secondary prevention group defined as high-risk by BQ walked 
a shorter distance than those defined as low-risk (28.3 ± 12.8 meters, p=0.029) 
after adjusting for confounding variables. In contrast, there was no significant 
difference in the 6MWT score between high- and low-risk patients based on 
the STOP-BANG and ESS.  
 
In the primary prevention group, patients defined as high-risk for SDB by 
STOP-BANG walked a longer distance (59.4 ±25.4 meters, p=0.022) than 
those defined as low-risk for SDB after adjusting for confounding variables. 
There was no significant difference in the distance walked between high- and 
low-risk subjects based on the BQ and ESS 






Figure 9. Distance walked by different groups of patients at high versus low  
SDB risk as defined by the three questionnaires.  




6.4.1 Screening for SDB Contributes to the Prediction of Exercise Fitness 
Among the three tested questionnaires which yielded fairly different risk 
assessment outcomes as shown, BQ is the only questionnaire that can predict 
exercise fitness in both the overall and secondary prevention groups. Patients 
who were classified as high risk for SDB by BQ walked significantly shorter 
distance than those at low risk.  
 
Notably, this trend is reversed in the primary prevention group. Although BQ 
and ESS were not able to predict exercise fitness in this particular group of 
subjects, STOP-BANG defined high risk subjects walked significantly longer 
distance than the low risk group. Adjustment for confounding effects was 
critical in this analysis, but impeded by the small sample size for the primary 
prevention group. Consequently, with confounding effects inadequately 
adjusted and the suspicion that the result was too heavily influenced by too 
few data, we reserve our confidence in this finding.  
 
6.4.2 Limitations 
The main drawback of this study is the small sample size representing those at 
high risk for SDB within the primary prevention group. This led to 
inconclusive result for the primary prevention group.  
 
It is also known that in general, SDB screening questionnaires are less 
powerful than the gold standard polysomnography study. The questionnaires 
have fairly high sensitivity but insufficient specificity to make an ideal 
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diagnostic test (El-Sayed, 2012). For instance, excessive day time sleepiness 
may be a symptom not only limited to SDB but also of other medical 
conditions such as narcolepsy (Johns, 1991). Nevertheless, due to the 
numerous disadvantages of polysomnography (high cost, limited availability, 
low compliance), screening questionnaires is a useful tool for the rapid 
identification of high risk individuals. 
 
6.4.3 Conclusion 
In conclusion, BQ is superior to ESS and STOP-BANG in predicting exercise 
fitness among patients attending cardiac rehabilitation, especially in those for 
secondary prevention. Individuals classified as high risk for SDB by BQ 
walked shorter distances than those at low risk. Given the significant 
prognostic value of exercise fitness in future cardiovascular events and 
mortality, it would be useful to incorporate the simple and rapid BQ during the 
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CHAPTER 7: SCREENING FOR SLEEP DISORDERED BREATHING 
IN THE ASSESSMENT OF CORONARY RISK 
7.1 INTRODUCTION 
SDB has been increasingly recognized as an emerging and treatable 
cardiovascular risk factor. However, SDB screening is rarely incorporated into 
health screening programs to date. 
 
In this study (SAVE), we determined the feasibility of including SDB 
screening as part of a coronary risk assessment program, and whether SDB is 
associated with coronary risk markers in an Asian community. While hs-CRP 
was the coronary risk marker of our primary focus, we also reported a panel of 














   CHAPTER 7 
 
 115 
7.2 MATERIALS AND METHODS 
7.2.1 SAVE Study Design 
This was a prospective study conducted at the Wellness Center of National 
University Hospital in Singapore between September 2014 and May 2016. 
Consecutive adults aged above 21 enrolled in a cardiovascular health 
screening package, which included laboratory and exercise treadmill tests, 
were approached for a SDB screening. A home-based, unsupervised, 
overnight sleep test was arranged for the participants. The exclusion criteria 
were known SDB based on previous sleep studies, any acute illnesses 
including ongoing infections, and inability to provide informed consent. The 
need to abstain from alcohol and hypnotics before the sleep test was 
highlighted to the participants. This study was conducted in accordance with 
the amended Declaration of Helsinki. The Singapore National Healthcare 
Group Domain Specific Review Board approved the research protocol 
(reference: DSRB−C/2013/00869), and informed consent was obtained from 
participants before the overnight sleep study. 
 
7.2.2 Anthropometry  
Anthropometric measurements were collected from the participants and these 
include age, gender, ethnicity, blood pressure, height, weight, BMI, neck and 
weight circumferences. Various cardiovascular risk factors (smoking, alcohol 
usage, dyslipidemia, hypertension, diabetes mellitus, family history of 
premature cardiovascular diseases) and presence of concomitant conditions 
were recorded.  
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7.2.3 Screening Questionnaires  
Participants completed the BQ and ESS to assess their risks of SDB and 
excessive day time sleepiness, respectively. We also conducted the InterHeart 
Risk Score questionnaire on a subgroup of 215 participants. All questionnaires 
were administered through face-to-face interviews upon recruitment at the 
Wellness Center. 
 
7.2.4 Home-Based Sleep Test 
To investigate the relationship between SDB and the various cardiovascular 
risk markers, all recruited participants were scheduled for an overnight sleep 
study regardless of their results on the two screening questionnaires. We 
aimed to conduct the sleep study within three days after the health screening, 
but postponement was allowed. Respiratory event scoring was performed 
using the latest 2012 AASM criteria (scoring hypopneas as at least a 30% 
reduction in airflow for at least 10s with desaturation of ≥ 3%). The study 
participants were then classified as with SDB (AHI ≥15) versus without SDB 
(AHI <15). All participants were informed of the sleep test results by mail.  
 
7.2.5 End Points 
The laboratory and exercise treadmill tests were performed at the hospital as 
part of the health screening package. The pre-specified laboratory−based 
coronary risk markers included hs-CRP, LDL−cholesterol, HDL−cholesterol, 
triglyceride and uric acid. The pre-specified exercise treadmill−based coronary 
risk markers included exercise time, heart rate recovery at 1−minute, heart rate 
recovery at 2−minute, and peak work load (expressed as METs). The 
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collection of coronary risk markers was led by an investigator (YY−C) who 
was blinded to the sleep study results.  
 
7.2.6 Statistical Analysis 
Using frequencies and percentages, we summarized the demographic and 
clinical characteristics that were categorical in nature and compared the 
differences between participants with SDB versus without SDB using the χ2 
test. Continuous variables were described using means and standard deviations 
if they were normally distributed, and the Student’s t test was used to compare 
differences in means. For skewed data, the median and interquartile ranges 
(IQR) were presented, and the Wilcoxon rank sum test implemented to 
compare medians.  
 
Multiple linear regression was implemented to examine the association 
between SDB and coronary risk markers. For markers that were skewed (hs-
CRP and triglyceride levels), we first carried out logarithmic transformation. 
As such, the effect of SDB on hs-CRP and triglyceride levels were interpreted 
in terms of relative mean difference based on a ratio of two geometric means. 
The parameter estimates of other non-transformed outcomes were interpreted 
in terms of absolute difference in mean, together with its associated 95% 
confidence interval. In the regression models, we pre−defined the following 
potential confounders for adjustment for all outcomes of interest: age, sex, 
BMI, hypertension and diabetes mellitus. All statistical analyses were 
generated using STATA v. 14 assuming a two-sided test based on the 
conventional 5% level of significance. 




7.3.1 Baseline Characteristics of SAVE Study Participants 
The study flow-chart is shown in Figure 10. A total of 696 individuals were 
screened for entry into the study. Six of them were excluded as they were 
known to have SDB and were undergoing treatment with continuous positive 
airway therapy, and 233 declined to participate in the study. Among the 457 
individuals who consented to participate in the SDB screening, 58 withdrew 
their consent before the overnight sleep study, 36 studies failed due to poor 
quality sleep tracings, four had known history of coronary artery disease, and 
one was found to suffer from predominantly central sleep apnea. After 
excluding the above 99 individuals, the remaining 358 participants formed the 
study cohort for the present analysis.  
 
The demographic and clinical characteristics of the study cohort are shown in 
Table 23. The mean BMI of the participants was 26 ± 4kg/m2. About 25% and 
12% of the recruited participants had hypertension and diabetes mellitus, 
respectively. None of the participants had a history of coronary 
revascularization, myocardial infarction, stroke, or chronic kidney disease. 
After the cardiovascular health screening, only one participant was found to 
have significant coronary artery disease and underwent percutaneous coronary 
intervention.   
 
Compared with the non−SDB group, the SDB group was older and more 
likely to be male, had higher BMI and prevalence of hyperlipidemia, 
hypertension, and diabetes mellitus.  



























Total number of individuals enrolled in a Cardiovascular 
Health Screening Program: 696 
457 individuals recruited  
222 (62%) in Non-SDB 
group 
233 refused  
6 with known SDB on CPAP 
treatment  
58 withdrew  
399 participants underwent the overnight sleep study  
136 (38%) in SDB group  
363 successful studies 
358 datasets included in cohort for analysis 
36 failed or poor studies 
1 Central sleep apnea  
4 History of PCI or MI  
AHI ≥ 15 AHI < 15 
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Table 23. Baseline demographics and clinical characteristics of study 
participants 








Age (years) 48±10 52±9 46±11 < 0.001 
Men 267 (75%) 118 (87%) 149 (67%) < 0.001 
Systolic Blood Pressure 
(mmHg) 119±14 124±13 116±13 < 0.001 
Diastolic Blood Pressure 
(mmHg) 76±10 79±9 74±10 < 0.001 
Height (m) 1.68±0.08 1.69±0.07 1.68±0.09 0.293 
Weight (kg) 74±14 78±13 71±14 < 0.001 
Body mass index (kg/m2) 26±4 27±4 25±4 < 0.001 
Neck circumference (cm) 39±4 41±4 38±4 < 0.001 
Waist circumference (cm) 93±11 98±10 90±11 < 0.001 
Cardiovascular risk factors     
  Smoking 50 (14%) 24 (18%) 26 (12%) 0.120 
  Alcohol consumption 135 (38%) 51 (38%) 84 (38%) 1.000 
  Hyperlipidemia 155 (44%) 75 (56%) 80 (36%) < 0.001 
  Hypertension 89 (25%) 47(35%) 42 (19%) 0.001 
  Diabetes mellitus 42 (12%) 27 (20%) 15 (7%) < 0.001 
  Family history of 
premature Coronary artery 
disease 
40 (11%) 13 (10%) 27 (12%) 0.493 
Data are presented as mean ± standard deviation or number (percentage).  
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7.3.2 Overnight Sleep Study 
Most (89.1%, 319 out of 358) of the recruited patients underwent the 
overnight sleep study within three days after the cardiovascular health 
screening, and the longest postponement was 49 days. The sleep study results 
of the participants with versus without OSA are shown in Table 24. The 
median AHI was 9.3 (IQR: 4.5 – 22). Based on AHI ≥15 events per hour, SDB 
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  AHI 
(events per 
hour) 
9.3 (4.5 – 22.0) 27.3 (20.0 – 40.2) 5.5 (3.0 – 8.2) < 0.001 
  ODI 
(events per 
hour) 
7.2 (3.2 – 18.9) 23.0 (16.3 – 31.9) 3.8 (2.0 – 6.3) < 0.001 
  Baseline 
SpO2 
94% (93 – 95) 93% (92 – 94) 95% (94 – 96) < 0.001 
  Lowest 
SpO2  
84% (79 – 88) 78% (72 – 83%) 87% (83 – 90) < 0.001 




7.4 (1 – 28) 24.1 (10 – 59) 1.5 (1 – 7) < 0.001 




1.7 (0.2 – 6.3) 5.4 (2.3 – 14.6%) 0.4 (0.1 – 1.6) < 0.001 
Abbreviations: SDB, sleep disordered breathing; AHI, apnea-hypopnea index; 
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7.3.3 Risk Stratification by Screening Questionnaires 
Based on the BQ, 36% of the participants were identified to be at high risk for 
SDB. Using the ESS cutoff of >10, 18% of the participants had excessive 
daytime sleepiness. There were more participants with than without SDB 
defined as high risk of having SDB by the BQ (53% versus 25%, p < 0.001) 
and having excessive daytime sleepiness (26% versus 14%, p = 0.005) 
 
The median InterHeart Risk Score was significantly higher in participants with 
SDB (14, IQR: 9 –17) than those without (9, IQR: 7 – 14, p<0.001). Likewise, 
there were more participants with (31%) than without (14%, p<0.001) SDB 
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7.3.4 Coronary Risk Markers 
The laboratory-based coronary risk marker analyses are shown in Table 25. 
The serum levels of hs-CRP (p<0.001), uric acid (p=0.004) and triglyceride 
(p<0.001) were higher among participants with than without SDB. Serum 
levels of HDL−cholesterol (p<0.001) were lower among participants with than 
without SDB. There were no significant differences in serum levels of 
LDL−cholesterol between participants with and without SDB. 
 
The exercise treadmill-based coronary risk marker analyses are shown in 
Table 26. The exercise time (seconds completed on the standard Bruce 
protocol) (p<0.001), heart rate recovery at 1-minute (p=0.001), heart rate 
recovery at 2- minute (p<0.001), and peak workload (p<0.001) were lower 
among participants with versus without SDB. 
 
The unadjusted, partially adjusted, and fully adjusted models are shown in 
Table 27. After full adjustment for age, sex, BMI, hypertension, and diabetes 
mellitus, SDB remained an independent predictor of serum levels of hs-CRP 
(relative mean difference 1.29; 95% confidence interval 1.03 to 1.62; 
p=0.025), triglyceride (relative mean difference 1.15; 95% confidence interval 
1.03 to 1.28; p=0.014), and exercise time (mean difference -26.4 s; 95% 
confidence interval to -51.6 to -1.2; p=0.04).  
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Table 25. Laboratory tests results 
Characteristics Overall (n=358) SDB (AHI≥15) (n=136) Non-SDB (AHI<15) (n=222) P value 
hs-CRP (mg/L) 1.1 (0.5 – 2.2) 1.4 (0.8 – 3.1) 0.9 (0.5 – 1.8) < 0.001 
Renal function      
   Urea (mmol/L) 4.61±1.09 4.69±1.09 4.56±1.08 0.294 
   Creatinine (µmol/L) 76±15 77±13 75±16 0.419 
   eGFR (mL/min)  98±14 97±12 99±15 0.093 
   Chloride (mmol/L) 103±2.2 103±2.3 104±2.0 < 0.001 
   Glucose (mmol/L) 5.2 (4.9 – 5.6) 5.5 (5.1 – 6) 5.1 (4.8 – 5.4) < 0.001 
   Calcium (mmol/L) 2.30±0.08 2.30±0.08 2.30±0.09 0.629 
   Calcium (corrected) (mmol/L) 2.28±0.07 2.27±0.07 2.29±0.07 0.063 
   Phosphate (mmol/L) 1.11 (1.03 – 1.20) 1.10 (1.05 – 1.19) 1.12 (1.02 – 1.22) 0.288 
   Uric acid (µmol/L) 368±78 383±79 359±76 0.004 
Liver function     
   Albumin (g/L) 43±2.4 43±2.5 43±2.4 0.256 
   Bilirubin (µmol/L) 14±5.3 14±5.3 14±5.4 0.731 
   Aspartate aminotransferase (U/L) 24 (20 – 29) 26 (21 – 31.5) 23 (19 - 27) < 0.001 
   Alanine aminotransferase (U/L) 25 (17 – 35) 29 (21 – 42) 21.5 (16 – 30) < 0.001 
   Alkaline phosphatase (U/L) 74±18 76±17 72±18 0.035 
Lipid profile     
   Cholesterol (mg/dl) 196±39  195±39 196±38 0.799 
   Triglyceride (mg/dl) 106 (82 – 166) 
1651.87) 
140 (96 – 194) 104 (74 – 143) < 0.001 
   HDL-C (mg/dl) 48± 1 45±11 50±11 < 0.001 
   LDL-C (mg/dl) 122±34 120±35 123±33 0.379 
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Blood counts     
   White Blood Cell (x 109/L) 6.25±1.49 6.54±1.70 6.07±1.32 0.004 
   Red Blood Cell (x 1012/L) 4.94±0.46 5.03±0.42 4.89±0.47 0.005 
   Hemoglobin (g/dL) 15±1.3 15±1.2 14±1.3 0.001 
   Hematocrit (%) 43±3.3 43±3.1 42±3.3 0.001 
   Red Cell Distribution Width (%) 13 (13 – 14)  13 (13 – 18) 13 (13 – 14) 0.533 
   Platelet (x 109/L) 254±56 257±55 253±56 0.514 
Endocrine markers     
   Thyroid-Stimulating Hormone (mIU/L) 1.67 (1.20 – 2.50) 1.75 (1.21 – 2.52) 1.57 (1.18 – 2.48) 0.304 
   Thyroxine (pmol/L) 12±1.5 12±1.5 12±1.6 0.931 
   HbA1c (%) 5.5 (5.3 – 5.9) 5.7 (5.4 – 6.2) 5.4 (5.2 – 5.7) < 0.001 
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Table 26. Exercise treadmill test results 
 
 
Characteristics Overall (n=358) SDB (AHI≥15) (n=136) 
Non-SDB (AHI<15) 
(n=222) P value 
Target heart rate (beats per minute) 146±9 143±8 148±9 < 0.001 
Maximum heart rate (beats per 
minute) 
172±11 168±9 174±11 < 0.001 
Archived heart rate (beats per minute) 159±13 154±13 162±12 < 0.001 
Chronotropic incompetence 8 (2.2%) 3 (2.2%) 5 (2.3%) 1.000 
Exercise time (seconds) 544±131 509±107 566±140 < 0.001 
Heart rate recovery 1 minute 27±9 25±9 28±9 0.001 
Heart rate recovery 2 minutes 48±12 45±11 50±12 < 0.001 
Heart rate recovery 3 minutes 56±12 52±11 58±13 < 0.001 
Heart rate recovery 4 minutes 59±13 55±11 62±13 < 0.001 
Heart rate recovery 5 minutes 62±13 57±12 65±13 < 0.001 
Abnormal heart rate recovery 13 (3.6%) 7 (5.2%) 6 (2.7%) 0.255 
Peak systolic blood pressure (mmHg) 186±26 192±25 183±26 0.002 
Peak work (metabolic equivalents) 11±2.4 10±1.9 11±2.6 < 0.001 
Angina index    0.381 
  No angina 356 (99.7%) 135 (99.3%) 221 (100.0%)  
  Exercise-limiting angina 1 (0.3%) 1 (0.7%) 0 (0.0%)  
Maximal ST-segment deviation    0.832 
  0 332 (93.3%) 129 (94.9%) 203 (92.7%)  
  1 16 (4.5%) 5 (3.7%) 11 (5.0%)  
  2 7 (2.0%) 2 (1.5%) 5 (2.3%)  
  3 1 (0.3%) 0 (0.0%) 1 (0.5%)  
Duke Treadmill Score 8.6±3.1 8.1±2.7 8.9±3.3 0.018 
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hs-CRP# 1.72 (1.37 to 
2.160 < 0.001 
1.31 (1.05 to 
1.64) 0.016 
1.31 (1.05 to 
1.64) 0.017 
1.29 (1.03 to 
1.62) 
0.025 
Triglyceride# 1.30 (1.17 to 
1.44) < 0.001 
1.16 (1.04 to 
1.29) 0.008 
1.16 (1.04 to 
1.29) 0.010 
1.15 (1.03 to 
1.28) 
0.014 
Uric Acid 24.3 (7.7 to 
40.8) 0.004 
-2.8 (-18.4 to 
12.9) 0.728 
-3.03 (-18.7 to 
12.6) 0.704 






-0.13 (-0.19 to 
-0.07) < 0.001 
-0.05 (-0.11 to 
0.01) 0.100 
-0.05 (-0.10 to 
0.01) 0.120 






-0.09 (-0.27 to 
0.10) 0.379 
-0.10 (-0.31 to 
0.11) 0.350 
-0.08 (-0.28 to 
0.13) 0.452 
-0.04 (-0.24 to 
0.16) 
0.725 
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aModels adjusted for age, sex, and body mass index. 
bModels adjusted for age, sex, body mass index, and hypertension. 
cModels adjusted for age, sex, body mass index, hypertension, and diabetes mellitus. 
# These variables have been log transformed, and hence the parameter estimate is interpreted in terms of relative mean difference, 
or ratio of two geometric mean 
 
Exercise time -57.7 (-85.1 to 
-30.2) < 0.001 
-29.7 (-54.9 to   
-4.5) 0.021 
-29.0 (-54.2 to -
3.8) 0.024 






-3.3 (-5.1 to -
1.4) 0.001 
-0.95 (-2.87 to 




-5.0 (-7.5 to -
2.6) 0.001 
-2.2 (-4.8 to 0.3) 0.089 -2.2 (-4.8 to 0.4) 0.093 -2.0 (-4.6 to 0.6) 0.125 
Peak work -1.04 (-1.55 to 
-0.54) < 0.001 
-0.52 (-0.98 to -
0.05) 0.030 
-0.51 (-0.97 to -
0.04) 0.033 
-0.46 (-0.92 to 
0.01) 
0.054 




7.4.1 SDB and Coronary Risk Markers 
Compared with participants without SDB, those with SDB had higher serum 
hs–CRP and triglyceride levels, and a lower exercise capacity (shorter exercise 
time). The associations remained significant after adjusting for age, sex, BMI, 
hypertension, and diabetes mellitus. 
 
7.4.2 Feasibility of SDB Screening in Health Screening Clinics 
It has been estimated that one-third of adults in the U.S. have at least one type 
of atherosclerotic vascular disease.(Berger, Jordan, Lloyd-Jones, & 
Blumenthal, 2010) There is increasing awareness among community 
individuals that coronary atherosclerosis could result in acute myocardial 
infarction and sudden death,(C. H. Lee et al., 2005) and some of these 
catastrophic events may be preventable through health screening and treatment. 
Although the effectiveness of cardiovascular health screening is still 
debatable,(Kypridemos et al., 2016) it is widely practised in many parts of the 
world. In the U.K., an action plan was launched in 2009 to promote 
cardiovascular health screening for all healthy adults for risk stratification and 
treatment of those at high risk.(Kypridemos et al., 2016)  
 
In this study, among the 696 participants enrolled at the health screening 
clinic, we found that only a small minority (0.9%, n=6) had a prior diagnosis 
of SDB. More than two-thirds of the participants agreed to undergo SDB 
screening as part of their cardiovascular health screening. Among those who 
had successfully completed the sleep study, the prevalence of SDB was 38%, 
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which is comparable to our previous estimated prevalence of 30.5% in 
Chapter 3. Our results suggest that health screening clinics are feasible sites 
for SDB screening, and a significant number of newly diagnosed SDB with 
increased coronary risks could be identified.  
 
To the best of our knowledge, this is the first report on the feasibility of 
incorporating SDB screening in cardiovascular health screening programs. 
With the observed associations between SDB and adverse cardiac events,(Kua 
et al., 2016; J. M. Marin, Carrizo, Vicente, & Agusti, 2005) under−diagnosis 
of SDB in community, and general acceptance of the participants to undergo 
sleep study, incorporating SDB screening into cardiovascular health screening 
could be beneficial to public health.   
 
7.4.3 Usefulness of SDB Screening Questionnaires  
Home-based sleep study using a portable diagnostic device was recently 
shown to be effective in diagnosing SDB regardless of the pre-test 
probability.(Guerrero et al., 2014) In this study, although the BQ and ESS 
were able to discriminate participants with versus without SDB (AHI cutoff of 
15), sensitivity was lower than reported in the studies performed in previous 
chapters: only half of the participants with SDB were classified as high risk by 
the BQ, and only a quarter of them had excessive daytime sleepiness. These 
were in accordance with a recent report in patients presenting with 
symptomatic coronary artery disease.(C.-H. Lee et al., 2016) With the 
increasing availability of sophisticated portable devices for home-based 
monitoring and its approval by the Center for Medicare and Medicaid Services 
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in 2008, it is conceivable that the use of screening questionnaires in 
contemporary era is limited. 
 
7.4.4 Limitations 
There are several limitations in this study. First, the participants in this study 
were self−referred to the health screening. This represented a selected group 
of community individuals who were more health−conscious. Second, the 
overnight sleep study was conducted using a portable diagnostic device 
instead of supervised in−laboratory polysomnography, primarily owing to the 
limited availability of in−laboratory polysomnography in our country. The 
portable diagnostic device lacks electroencephalogram, and thus does not 
discriminate wakefulness from sleep and does not detect arousals. Therefore, 
there may be an underestimation of the disease severity as AHI was calculated 
using the total recording time instead of the actual sleep duration. In addition, 
unattended studies are more prone to data loss compared with in−laboratory 
polysomnography.(Collop et al., 2007) This is reflected in the 36 (9%) 
participants excluded due to failed or poor quality tracings in our study. Third, 
we are unable to evaluate gender effects in this study as our data set consists 
of only a small number of female participants (n=91, 25%).  
 
7.4.5 Conclusion 
In conclusion, it appears feasible to incorporate SDB screening into health 
screening clinics. There is a high prevalence of previously undiagnosed SDB 
among participants of cardiovascular health screening, and SDB is 
independently associated with coronary risk markers in this patient cohort. 
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This study depicts clinical feasibility, and future studies to explore the clinical 
usefulness and cost-effectiveness are warranted. 
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CHAPTER 8: CONCLUSION AND FUTURE PERSPECTIVES 
Firstly, the prevalence of SDB among community individuals from the three 
different major ethnic groups (Chinese, Malay and Indian) in Singapore was 
investigated. The awareness of SDB in this community and the factors that 
affect their knowledge were also surveyed. It was found that SDB was 
prevalent but mostly undiagnosed and its awareness is poor in Singapore. 
Indians had lower odds of moderate-to-severe SDB compared to Chinese even 
after accounting for BMI differences. More strategies are needed to optimize 
diagnosis and recognize ethnic differences in SDB prevalence. Considerable 
educational effort, targeted at community individuals who had low education 
backgrounds and of Malay and Indian races is needed to raise public 
awareness which could improve the detection of SDB. 
 
Next, we looked at the usefulness of the commonly employed SDB screening 
questionnaires (STOP-BANG and BQ) in predicting SDB among community 
individuals in Singapore. We also further explored whether lowering the BMI 
cutoffs of the STOP-BANG questionnaire would improve its predictive 
performance. Results show that both STOP-BANG and BQ may be useful as 
screening tools in the local general population setting in view of their good 
sensitivities and high negative predictive values in ruling out severe SDB 
(AHI ≥30). Both questionnaires and could help to identify high-risk subjects 
who may benefit from more urgent evaluation and treatment. Furthermore, 
different BMI cutoffs did not change the performance of STOP-BANG 
questionnaire significantly, hence the cutoff of BMI >35 can be used for obese 
individuals in the local population. 
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In addition, the validity of the newly developed NoSAS score in the local 
community was examined and its performance was compared with the STOP-
BANG and BQ. We found that the NoSAS score performed similarly to the 
STOP-BANG and BQ in our multiethnic Asian cohort in ruling out severe 
SDB and all three have utility as screening tools. Ultimately, the choice of 
questionnaire to be used might then depend on its simplicity and objectivity. 
Future studies will be needed to determine which questionnaire will be most 
widely used in clinical settings. 
 
The applicability of three SDB screening questionnaires (STOP-BANG, BQ 
and ESS) in predicting exercise fitness was also studied in a cohort of patients 
attending cardiac rehabilitation who were either at-risk of or with confirmed 
cardiovascular disease. BQ was found to be superior to STOP-BANG and ESS 
in predicting exercise fitness in patients attending cardiac rehabilitation, 
especially for secondary prevention as those classified as high risk for SDB by 
BQ walked shorter distances than those at low risk. Given the significant 
prognostic value of exercise fitness in future cardiovascular events and 
mortality, it would be useful to incorporate the simple and rapid BQ during the 
screening of patients referred for cardiac rehabilitation. 
 
Lastly, the feasibility of including SDB screening into cardiovascular health 
screening programs was investigated. The associations of SDB with various 
coronary risk markers tested as part of the health screening package were also 
examined. SDB was found to be independently associated with serum hs-CRP 
and triglyceride levels, and lower exercise capacity among participants of 
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cardiovascular health screening. Together with the observed acceptance for 
SDB screening, gross under-diagnosis and high prevalence of SDB, 
incorporation of SDB screening into cardiovascular health screening programs 
is practicable and could help prevent or reduce SDB, and its adverse 
cardiovascular consequences. In the future, research to determine the effects 
of SDB–directed therapies on coronary risk markers and the cost–
effectiveness of SDB screening using portable diagnostic device in health 
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Figure S1. Weighted, estimated population prevalence rates for SDB using 
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Table S1. Weighted estimates of population demographics across racial 










Sex      
  Men 49.3 49.4 52.3 47.6 0.82 
  Women 50.7 50.6 47.7 52.4  
Age, years 43.8 ± 0.7 41.2 ± 0.6 40.7 ± 0.7 39.7 ± 1.5 <0.001 
Age group      
  21-40 years 44.2 48.4 53.9 56.1 0.001 
  41-60 years 39.7 40.7 35.5 36.8  
  ≥ 61 years 16.1 10.9 10.6 7.1  
BMI, (kg/m2)† 23.3 ± 0.2 26.0 ± 0.2 25.5 ± 0.2 24.6 ± 0.5 <0.001 
BMI category      
  BMI < 23 
kg/m2 
52.5 31.9 28.7 39.7 <0.001 
  BMI = 23-27.5 
kg/m2          
33.6 34.2 45.2 39.4  
  BMI > 27.5 
kg/m2 
13.9 33.9 26.1 20.9  
Diabetes† 6.6 8.3 11.0 2.1 0.007 
Hypertension† 13.7 15.7 14.2 9.9 0.4 
Smokers 14.2 31.1 16.6 11.6 <0.001 
Drinkers      
  Never 37.2 89.6 55.9 36.1 <0.001 
  Occasionally 52.1 7.6 33.1 46.5  
  Frequent 10.7 2.8 11.0 17.4  
Unemployed*† 1.8 2.5 2.4 3.9 0.5 
Snorers† 14.6 19.8 12.6 17.4 0.06 
Data are presented as mean ± SD or percentage.  
BMI, body mass index. 
*Persons are counted as unemployed, if they are not working, but are actively 
looking and available for work.  
† 2182, 2299, 2298, 2319 and 1984 subjects completed the baseline 
examination for the variables of BMI, Diabetes, Hypertension, Unemployment 
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Table S2. Weighted estimates of demographic and sleep test data by SDB 
severity 
Data are presented as mean ± standard deviation or percentage. 
 
AHI, apnoea–hypopnoea index; BMI, body mass index; ODI, oxygen 
desaturation index defined as number of 3% drops in oxygen saturation per 
hour of sleep; SpO2, arterial oxygen saturation. 
 
  





Sex    
  Men 42.7 64.6 0.04 
  Women 57.3 35.4  
Age, years 46.2 ± 1.5 51.9 ± 2.1 <0.001 
BMI, kg/m2 24.1 ± 0.4 26.7 ± 0.8 <0.001 
Neck circumference, cm 34.9 ± 0.4 37.7 ± 0.6 <0.001 
Waist circumference, cm 85.4 ± 1.3 93.4 ± 1.9 <0.001 
Diabetes 5.9 11.5 0.22 
Hypertension 9.2 23.0 0.02 
Smokers 15.6 13.2 0.71 
Drinkers    
  Never 42.2 39.3 0.8 
  Occasionally 49.3 47.8  
  Frequent 8.5 12.9  
Snorers 43.9 53.2 0.09 
ODI 4.7 ± 0.4 22.7 ± 2.9 <0.001 
Baseline SpO2, % 94.8 ± 0.1 93.8 ± 0.2 <0.001 
Lowest SpO2, % 86.1 ± 0.5 76.1 ± 1.6 <0.001 
Total time SpO2 < 90%, 
min 
5.0 ± 1.7 31.8 ± 8.1 <0.001 
Epworth Sleepiness Scale 
score 
6.8 ± 0.4 6.0 ± 0.8 0.128 
  153 
Table S3. Predictive parameters for STOP-Bang questionnaire using AASM 
2007 scoring criteria 
 
 AHI4 ≥15 AHI4 ≥30 
Sensitivity, % 67.9 (54.0-79.7) 75.0 (50.9-91.3) 
Specificity, % 72.6 (65.6-78.9) 66.7 (60.0-72.8) 
PPV, % 42.7 (32.3-53.6) 16.9 (9.8-26.3) 
NPV, % 88.2 (82.0-92.9) 96.7 (92.5-98.9) 
LR+ 2.47 2.25 
LR- 0.44 0.38 
Area under ROC 
curve 
0.797 (0.682-0.912) 0.776 (0.651-0.901) 
Data are presented as average (95% confidence interval). 
AHI4, apnea-hypopnea index using 4% oxygen desaturation criteria to score 
hypopneas;  
NPV, negative predictive value; PPV, positive predictive value; LR+, positive 
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Table S4. Predictive parameters of STOP-BANG for AHI4 defined moderate-
to-severe and severe SDB using different BMI cutoffs 
 
 BMI ≥ 35 BMI ≥ 30 BMI ≥ 27.5 
AHI4 ≥15    
  Sensitivity, % 67.9 (54.0-79.7) 71.4 (57.8-82.7) 71.4 (57.8-82.7) 
  Specificity, % 72.6 (65.6-78.9) 70.1 (63.9-77.4) 67.7 (60.5-74.4) 
  PPV, % 42.7 (32.3-53.6) 42.6 (32.4-53.2) 40.0 (30.3-50.2) 
  NPV, % 88.2 (82.0-92.9) 89.2 (83.0-93.7) 88.7 (82.3-93.4) 








AHI4 ≥30    
  Sensitivity, % 75.0 (50.9-91.3) 80.0 (56.3-94.3) 80.0 (56.3-94.3) 
  Specificity, % 66.7 (60.0-72.8) 64.9 (58.2-71.1) 62.2 (55.4-68.6) 
  PPV, % 16.9 (9.8-26.3) 17.0 (10.1-26.2) 16.0 (9.3-24.7) 
  NPV, % 96.7 (92.5-98.9) 97.3 (93.2-99.3) 97.2 (92.9-99.2) 








Data are presented as average (95% confidence interval). 
AHI4, apnea-hypopnea index using 4% oxygen desaturation criteria to score 
hypopneas; BMI, body mass index; NPV, negative predictive value; PPV, 
positive predictive value; ROC, receiver operating characteristics. 
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Table S5. Predictive parameters for Berlin questionnaire using AASM 2007 
scoring criteria 
 
 AHI4 ≥ 15 AHI4 ≥ 30 
Prevalence of SDB, 
% 
22.7 8.3 
Sensitivity, % 64.3 (50.4-76.6) 80.0 (56.3-94.3) 
Specificity, % 76.8 (70.1-82.7) 71.6 (65.2-77.5) 
PPV, % 45.6 (34.3-57.2) 20.3 (12.0-30.8) 
NPV, % 87.7 (81.7-92.3) 97.5 (93.8-99.3) 
LR+ 2.78 2.81 
LR- 0.46 0.28 
Area under ROC 
curve 
0.706 (0.635-0.776) 0.758 (0.663-0.853) 
Data are presented as average (95% confidence interval). 
Prevalence of SDB using AHI4 scoring criteria 
AHI4, apnea-hypopnea index using 4% oxygen desaturation criteria to score 
hypopneas;  
NPV, negative predictive value; PPV, positive predictive value; LR+, positive 
likelihood ratio; LR-, negative likelihood ratio; ROC, receiver operating 
characteristics. 
 
 
 
 
